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Research Highlights 
 Much research has examined biomarkers of chronic stress in dementia caregivers 
 Cortisol was increased in dementia caregivers in most studies examining cortisol 
 Dementia caregivers displayed poorer attention and executive function performance 
 Interventions to reduce stress in caregivers may improve cognition 
 Risk of bias was generally low to moderate 
 
 
Abstract 
 
As the physiological impact of chronic stress is difficult to study in humans, naturalistic 
stressors are invaluable sources of information in this area. This review systematically 
evaluates the research literature examining biomarkers of chronic stress, including 
neurocognition, in informal dementia caregivers.  
We identified 151 papers for inclusion in the final review, including papers examining 
differences between caregivers and controls as well as interventions aimed at counteracting the 
biological burden of chronic caregiving stress.  
Results indicate that cortisol was increased in caregivers in a majority of studies examining 
this biomarker. There was mixed evidence for differences in epinephrine, norepinephrine and 
other cardiovascular markers. There was a high level of heterogeneity in immune system 
measures. Caregivers performed more poorly on attention and executive functioning tests. 
There was mixed evidence for memory performance. Interventions to reduce stress improved 
cognition but had mixed effects on cortisol. Risk of bias was generally low to moderate. Given 
the rising need for family caregivers worldwide, the implications of these findings can no 
longer be neglected. 
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Introduction 
The role of an informal dementia caregiver (i.e. a person providing care to a person with 
dementia, who is not providing this care in a professional capacity) is a potential source of 
substantial psychosocial stress. Patients with dementia may depend increasingly upon informal 
caregivers, typically close family members, to help them with activities of daily living, as well 
as displaying challenging behaviours and facing safety issues. In addition to heightened stress, 
family dementia caregivers show increased levels of anxiety and depression (Baumgarten et 
al., 1994; Mahoney et al., 2005). Although many informal family caregivers display resilience 
in the face of their relatives’ illness, there is a clear mental health risk within this group. The 
social impact of this care should not be underestimated; the worldwide economic cost of 
dementia has been estimated at US$818 billion, and it is predicted that this figure will increase 
to $2 trillion by 2030 (Prince et al., 2015). Within this context, family caregiving saves the 
exchequer spending on care provision. The results of research on the chronic stress of caring 
for people with dementia can be used to provide targeted interventions for attenuating the 
impact of stress in this group, and potentially in other groups exposed to chronic stressors. 
Although there has been much research on the biological and psychological markers that 
accompany the acute stress response (Allen et al., 2014; Dickerson and Kemeny, 2004), it is 
unethical to experimentally expose humans to chronic stress. As a result, naturalistic chronic 
stressors such as dementia caregiving are a useful means for examining the impact of chronic 
stress on human physiology. A number of such models have been examined, such as 
unemployment (Dettenborn et al., 2010; Gallagher et al., 2016; Ockenfels et al., 1995), or the 
ongoing effects of childhood abuse (Carpenter et al., 2009; Penza et al., 2003). Compared to 
other forms of caregiving, caregiving for a family member with dementia may be a particularly 
stressful experience (Clipp and George, 1993; Kim and Schulz, 2008). Estimates of median 
survival time for dementia patients vary between 3.3 years and 11.7 years (Todd et al., 2013), 
and so dementia caregiving represents a chronic source of stress.   
Biomarker research may provide us with a greater understanding of mechanisms through 
which psychological stress may impact upon long-term health outcomes. For instance, 
increases in blood pressure may act to increase the risk of cardiovascular illness (MacMahon 
et al., 1990) and compromised immune system functioning can impair resistance or response 
to infectious diseases such as influenza (Godbout and Glaser, 2006).  Given that ageing and 
chronic stress can have similar effects on the brain (Prenderville et al., 2015), the impact of 
caregiving stress may be compounded where caregivers for elderly relatives are themselves 
senior citizens. However, this also raises the methodological caveat that the search for 
biomarkers of caregiver stress should take into account the age of the caregiver, as well the 
nature of impairment and changes in caregiving intensity (Lovell and Wetherell, 2011). 
The key aim of this paper is to describe the results of a systematic review of the literature 
examining the biological and psychological burden of the chronic stress of dementia 
caregiving. We also review research looking at interventions to reduce the impact of chronic 
stress in caregivers, where biomarkers are examined as an outcome. We appraise the research 
quality of relevant research and identify potential future directions for research in this area.  
1. Methods 
This systematic review was pre-registered at PROSPERO. ID: PROSPERO 
2015:CRD42015020828. The date of registration was 28th May 2015. This is available from: 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015020828 
2.1. Literature search 
The databases Cinahl, PsycINFO, Pubmed, ScienceDirect, Scopus and Web of Knowledge 
were used as electronic search engines for the systematic review. 
The search terms included were: “caregiver” AND “dementia” AND “stress” OR “allostatic 
load” OR “biomarkers” OR “biological marker” OR “cortisol” OR “cytokine” OR “heart rate” 
OR “gastrointestinal” OR “interleukin” OR “c-reactive protein” OR “catecholamines” OR 
“adrenaline” OR “noradrenaline” OR “epinephrine” OR “norepinephrine” OR “pH” OR 
“amylase” OR “vasopressin” OR “DHEA” OR “DHEA-S” OR “lymphocyte” OR “T-cell” OR 
“B-cell” OR “monocyte” OR “neutrophil” OR “basophil” OR “granulocyte” OR 
“macrophage” OR “nuclear factor kappa B” OR “immunoglobulin” OR  “heart rate variability” 
OR “BDNF” OR “d-dimer” OR “tryptophan” OR “kynurenine” OR “blood pressure”.  
2.2. Exclusion criteria  
Studies were excluded if they were not written in English (and a translation was not available), 
if they did not report original research, if they did not employ a quantitative design, if they did 
not assess any biomarkers or if they did not assess informal caregivers (i.e. those caring in a 
non-professional capacity) for patients with dementia. Study review and selection was 
completed by two reviewers. See Figure 1 for flowchart of study exclusion/inclusion. 
2.3. Data Extraction 
Two reviewers extracted data on study design, control group, length of follow up, region and 
time period of study, outcome definitions, interventions, compliance with the intervention, data 
source, sample size, attrition rate, treatment of missing values, confounders considered, 
patient’s dementia diagnosis, inclusion/exclusion criteria for study participants and participant 
age, gender, ethnicity, and relation to care recipient. 
2.4. Study evaluation 
Quality was assessed via a tool based on McDonald et al. (2005), but adapted for the context 
of dementia caregiving. This quality assessment tool assessed six types of bias: 1. selection 
(sample selection, rationale for control group and length of assessment, and provision of 
inclusion/exclusion criteria), 2. Exposure (hours of caring per week, overall duration of caring 
and assistance with activities of daily living), 3. outcome (description of biomarker 
assessment), 4.confounding (number of potential confounding factors controlled for), 5.  
analytic (adequately explanation of statistical methods, application of correction for multiple 
comparisons where appropriate and sample size adequacy), 6. attrition (rate of attrition and 
explanation for attrition).   
For each article, the six types of bias were classified as low, moderate or high (see 
Supplementary Table 1 for quality assessment form with detailed description). Furthermore, 
overall study bias was classified as low, low-moderate, moderate, moderate-high or high, based 
on an arithmetic mean of bias from the six types of bias. The second reviewer verified the 
quality assessment of the first reviewer. 
2. Results 
Of the 8,697 papers initially identified, a total of 151 studies were included in the systematic 
review (see Figure 1 for inclusion flowchart). This included 133 studies examining the impact 
of dementia caregiving on stress biomarkers and 18 papers examining the impact of 
interventions to reduce stress in carers. 
3.1. Impact of dementia caregiving on biomarkers of stress 
3.1.1. Dementia caregiving and cortisol 
Thirty one non-interventional studies examined cortisol levels in dementia caregivers (See 
Table 1). Of these, twenty-six examined salivary cortisol, three examined plasma cortisol, three 
examined urinary cortisol, and one looked at hair cortisol (with some studies examining cortisol 
from multiple sources).  
Heightened cortisol was observed in caregivers in sixteen studies (not including studies that 
focused on factors moderating cortisol output). Of these, seven studies showed increased 
salivary cortisol when measured at various timepoints throughout the day (Bauer et al., 2000; 
Da Roza Davis and Cowen, 2001; Davis et al., 2004; Gallagher-Thompson et al., 2006; Palma 
et al., 2011; Tarrier et al., 2002; Vedhara et al., 1999). In particular, there was evidence from 
four other studies of increased salivary cortisol at awakening (de Vugt et al., 2005; Fonareva 
et al., 2011; Oken et al., 2011; Wahbeh et al., 2008) although both an attenuated cortisol 
awakening response (de Vugt et al., 2005) and Wahbeh et al. (2008) found a clear cortisol 
awakening response in caregivers at 30 minutes, but not in a non-caregiver control group. 
Increased cumulative stress load, as indicated from hair cortisol measures, has been reported 
(Stalder et al., 2014) as has an increase in overnight urinary cortisol (Clark et al., 2007). In 
terms of response to an acute stressor, both increased saliva cortisol reactivity (Aschbacher et 
al., 2013) and increased plasma cortisol have been documented (Cacioppo et al., 2000).    
The effect of caregiving on cortisol is not always apparent and studies have also found that 
plasma morning cortisol is unchanged (Irwin et al., 1997; Mills et al., 1997), that there was no 
difference in salivary cortisol at various timepoints throughout the day or in 12-hour urinary 
cortisol (Tomiyama et al., 2012) and that there were no differences in plasma cortisol change 
in response to an acute stressor (Malarkey et al., 1996).  
Hypofunction of the HPA axis has also been reported including a reduction in salivary cortisol 
measured at various timepoints over the day (Jeckel et al., 2010). Deviations from the normal 
profile despite similar peak levels in caregivers include an earlier onset of salivary cortisol 
reactivity in response to acute stress (Epel et al., 2010). One study indicated an increased ratio 
of salivary cortisol to dehydroepiandrosterone (DHEA), which has neuroprotective and 
antiglucocorticoid effects, suggesting an imbalance in HPA axis activity (Correa et al., 2015). 
Similarly, another study indicated an increase in salivary dehydroepiandrosterone sulfate 
(DHEA-S) to cortisol (Jeckel et al., 2010). 
A number of moderating factors were observed: age and ethnicity (McCallum et al., 2006; 
Wilcox et al., 2005) as well as cultural values (Holland et al., 2010), psychological factors: 
coping style (Merritt and McCallum, 2013; Merritt et al., 2011) and depressed mood (Leggett 
et al., 2014), caring circumstances: adult day services (Klein et al., 2014) as well as admission 
and discharge (Neri et al., 2007), and genotype (Brummett et al., 2008).  
In summary, the majority of studies using cortisol as a stress readout have revealed abnormal 
HPA axis function and most support hyperactivity. These assessments vary in terms of timing, 
the type of biological sample assessed and whether baseline measures or HPA axis challenges 
were used. We note that many of the studies reported included multiple time points which is 
critical given the concerns noted with single time point assessments of cortisol (e.g. Allen et 
al., 2014). Interestingly, there was evidence of alterations in cumulative stress load, the cortisol 
awakening response, the diurnal profile of cortisol secretion and the response to an acute 
stressor. This type of profile suggests that caregivers are exposed to the damaging effects of 
elevated cortisol across the day and over sustained periods of time; such elevation is known to 
be associated with psychopathology, including depression (e.g. Dinan, 2001),  and irritable 
bowel syndrome (e.g. Kennedy et al., 2014). 
3.1.2. Dementia caregiving and the immune system 
Fifty-four non-interventional studies examined either immune system activation or response 
in dementia caregivers (See Table 2). Differences between caregivers and non-caregivers have 
been demonstrated by basal comparisons; caregivers had increased peripheral blood levels of 
C-reactive protein (Fonareva et al., 2011; Gouin et al., 2012), and a longer duration of care was 
associated with higher levels (Von Känel et al., 2012c), although other studies did not indicate 
differences (Vitaliano et al., 2007; Von Känel et al., 2006b). There is mixed evidence 
concerning whether IL-6  levels differ in caregivers (Fonareva et al., 2011; Gouin et al., 2012; 
Kiecolt-Glaser et al., 2003; Segerstrom et al., 2008; Von Känel et al., 2006b) and TNF-alpha 
(Fonareva et al., 2011; Von Känel et al., 2012c). Caregivers had an increased percentage of IL-
10+, but no difference for cells expressing IL-2 or IFN-gamma in the cytoplasm of CD-4+ and 
CD-8+ lymphocytes (Glaser et al., 2001) or peripheral IL-2 levels (Neri et al., 2007). Caregivers 
did not have altered IgA secretion (Bristow et al., 2008; Neri et al., 2007) and did not differ in 
lymphocyte full blood counts (Bauer et al., 2000; Reese et al., 1994). Differences in 
lymphocyte levels in caregivers were lymphocyte-type specific (Mills et al., 1999) while they 
did not differ for NK cell counts (Reese et al., 1994), NK cell activity or cytotoxic activity 
(Irwin et al., 1991; Vitaliano et al., 2001). 
There is evidence that the immune response to challenge is altered in caregivers. Caregivers 
had a reduced IL-1beta response to LPS stimulation, along with slower wound healing 
(Kiecolt-Glaser et al., 1995). Caregivers also had reduced leukocyte response to mitogens 
(Cacioppo et al., 1998), reduced mitogen-induced lymphocyte proliferation, reduced mitogen-
induced IL-2 production, and reduced lymphocyte sensitivity to glucocorticoids (Bauer et al., 
2000). Although caregivers did not differ in lymphocyte full blood counts, they had lower T-
cell proliferation in response to phytohaemagluttinin (PHA) stimulation (Bauer et al., 2000; 
Reese et al., 1994). Caregivers did not differ in percentage T or B cells, monocytes or NK cells, 
but following stimulation with anti CD-3 and anti-CD28 Abs had lower T-cell proliferation 
and heightened production of cytokines (TNF-α and IL-10) (Damjanovic et al., 2007), although 
another study found increased proliferation of mitogen-stimulated T-cells to glucocorticoid 
challenge (Jeckel et al., 2010). Caregivers had reduced NK response to rIL-2 or rIFN-gamma 
(Esterling et al., 1994; Esterling et al., 1996).   
In addition to in vitro evidence, caregivers had reduced antibody titre responses to the Fluzone 
vaccine and a more rapid reduction in peripheral blood leukocytes (PBL) ability to synthesize 
IL-2 after vaccine stimulation (Glaser et al., 1998), although other research did not indicate 
differences in antibody titres to influenza vaccine (Segerstrom et al., 2008; Vedhara et al., 
1999). In contrast, increased antibody titres to HSV-1, with a reduced t-cell proliferative 
response to HSV-1 (Glaser and Kiecolt-Glaser, 1997), as well as increased antibody titres to 
EBV virus capsid antigen IgG have been reported. Caregivers also had reduced IgC titres over 
six months in response to pneumococcal pneumonia vaccination (Glaser et al., 2000).  
There is evidence that immune activity in response to acute psychosocial stress is altered in 
caregivers: in response to a speech stressor, leukocytes were increased and the density of L-
selectin was reduced in caregivers (Adler et al., 2002), and there was evidence of increased 
reactivity and delayed recovery of P-selectin (Aschbacher et al., 2008). Depression acted as a 
significant predictor of P-selectin reactivity (Aschbacher et al., 2009). Cell adhesion molecules 
such as L- and P-selectin may have a significant impact upon the immune system’s 
preparedness to mount a response to challenge (e.g. Dhabhar et al., 1994). Caregivers showed 
no differences in chemotaxis to the beta-adrenergic agonist, isoproteronol (ISO), or to stromal 
cell-derived factor-1 (SDF-1), N-formyl-methionyl-leucyl-phenylalanine (FMLP) but reduced 
FMLP and SDF-1 chemotaxic responses to an acute psychosocial stressor (Redwine et al., 
2004).  
Beta(2)-adrenergic receptor sensitivity is important for peripheral blood mononuclear cell 
(PBMC) trafficking and cytokine production. Caregiving overload, that is, feelings that carers 
were overloaded by their role, as assessed with the Pearlin Role Overload scale (Pearlin et al., 
1990) was negatively associated with beta-adrenergic receptor sensitivity, which was also 
negatively associated with caregiver mastery (Mausbach et al., 2008; Mausbach et al., 2007b). 
Beta-adrenergic receptor sensitivity was lower in caregivers classified as more vulnerable due 
to increased care demands (Mills et al., 2004).  
A number of moderating effects on immune system activity have been described, including 
age (Irwin et al., 1997; Kiecolt-Glaser et al., 1996; Mills et al., 1997), as well as gender (Mills 
et al., 1997; 2009; Thompson et al., 2004), and males caring for spouse with more severe 
dementia had increased IL-6 levels compared to females caring for a spouse with more severe 
dementia (Von Känel et al., 2006a) disease status/medical treatment: oral or transdermal 
hormone replacement therapy with the majority taking estrogen only or estrogen and 
progesterone (Aschbacher et al., 2007), cancer history (Vitaliano et al., 1998a) and depression 
(Castle et al., 1995; Scanlan et al., 2001). A number of psychological factors have been found 
to moderate the effects of caregiver stress, including childhood abuse (Kiecolt-Glaser et al., 
2011), life stress rating (Mills et al., 1997) sleep levels (Von Känel et al., 2010a) and leisure 
satisfaction –for TNF-alpha, IL-8, IFN-gamma, but not for IL-6 or CRP (Von Känel et al., 
2014). In addition to these moderating effects, there was a mediating effect of bodily pain on 
CRP levels in caregivers, who also reported higher bodily pain than non-caregivers (Graham 
et al., 2006). 
Given findings that caregivers are prone to more days with infectious illness (Kiecolt-Glaser 
et al., 1991), a greater understanding of immune system changes in dementia caregivers is 
warranted. In summary, immune system function has been assessed in a variety of ways, 
including both directly and indirectly, at baseline and following challenges, and via multiple 
different methodologies. Piecing together the information from these disparate approaches is 
challenging, and more consistent assessment strategies would benefit the field. Baseline levels 
of cytokines and acute phase markers such as IL-6, TNF-alpha and CRP which are most 
frequently assessed in psychiatric populations, and which yield robust results in such 
populations (Goldsmith et al., 2016), have infrequently been assessed in caregivers and the 
results have been mixed.  Interestingly, depression is associated with both HPA axis 
hyperactivity and immune system activation and this has been ascribed to impaired 
glucocorticoid receptor function (Pariante & Lightman, 2008). Although baseline low grade 
immune system activation is apparent in some caregiver studies, the evidence for this is mixed; 
there is clearer evidence that the responsivity of the immune system to challenge may be 
compromised following caregiver stress. More careful target selection will be required in future 
studies to get a clearer picture of immune system function in caregivers and these studies will 
need to take account of factors such as duration of caregiving and caregiver burden scores. 
Importantly, there are well defined routes through which immune system activation can impact 
at the level of the CNS and a number of anti-inflammatory strategies to counteract such 
activation. It is premature based on the current data to conclude this would be beneficial in 
caregivers. Equally, the possibility of a compromised immune system reactivity needs to be 
considered.  
 
3.1.3. Dementia caregiving and cardiovascular biomarkers  
 Forty seven non-interventional studies examined cardiovascular variables in dementia 
caregivers (see Table 3). Caregivers had higher resting heart rate (HR) (Cacioppo et al., 2000; 
Jeckel et al., 2010), systolic blood pressure (SBP) (Cacioppo et al., 2000) and diastolic blood 
pressure (DBP) (Cacioppo et al., 2000; Jeckel et al., 2010), although other studies found no 
difference for caregivers in SBP or DBP (Malarkey et al., 1996; Redwine et al., 2004). Further 
research has found heightened mean arterial pressure in caregivers (Malarkey et al., 1996; 
Mausbach et al., 2007c; Redwine et al., 2004). Although one cross-sectional study suggested 
that there were comparable age-related increases in SBP and HR (Uchino et al., 1992), another 
study found that although there was not a significant difference in blood pressure (BP) at 
baseline, BP readings consistent with borderline hypertension were more common in 
caregivers over a six-year follow-up (Shaw et al., 1999), and longitudinal increase in DBP was 
related to increase ADL assistance (Shaw et al., 2003). Hospice care was not associated with 
changes in BP (Irwin et al., 2013).  
D-dimer, a hypercoagulability marker that may also be considered a marker of psychosocial 
distress (Von Känel and Dimsdale, 2003) has been found to be increased in caregivers (Von 
Känel et al., 2005; Von Känel et al., 2006b), although not after controlling for anxiety and 
depression (Aschbacher et al., 2005). Clinical dementia rating of the patient was found to be 
associated with increased baseline D-dimer and D-dimer reactivity (Aschbacher et al., 2006), 
and higher negative life events were associated with higher D-dimer (Von Känel et al., 2003). 
Death or placement of the patient is associated with a drop in D-dimer, but only after 6 months 
or more (Mausbach et al., 2007a). Caregiver had increased tissue-type plasminogen activator 
antigen over time (Mausbach et al., 2007c), although this was not observed in another report 
(Von Känel et al., 2005).  
A number of composite measures incorporating cardiovascular factors have been assessed in 
caregivers. A composite measure of allostatic load (based on BP, BMI , NE, EPI, cholesterol) 
was increased in caregivers (Roepke et al., 2011b), while a composite measure of metabolic 
syndrome (based on glycosylated hemoglobin concentration, triglycerides, waist 
circumference and blood pressure) was significantly associated with the patient’s cognitive 
decline (Brummett et al., 2013). Another study did not find a difference for caregivers in a 
cardiovascular composite based on MAP, HDL and NK cell activity (Vitaliano et al., 2001). A 
higher rate of problem behaviours by the patient was associated with an increased procoagulent 
index, derived from von Wildebrand factor, Plasminogen Activator Inhibitor-1, and D-dimer 
scores (Von Känel et al., 2010b).  
A number of other cardiovascular measures have been examined in caregivers, who have been 
shown to have a higher low frequency/high frequency (LF/HF) ratio (an index of sympathetic 
activity) during the first half of sleep (Sakurai et al., 2015). Higher burdens in caregivers were 
associated with lower levels of heart coherence (Sarabia-Cobo, 2015). Caregivers had shorter 
cardiac pre-ejection periods (Cacioppo et al., 2000), but did not differ from controls in 
respiratory sinus arrhythmia (Cacioppo et al., 2000; Malarkey et al., 1996). Number of years 
caring and severity of dementia were associated with lower hyperemia induced flow-mediated 
dilation (Mausbach et al., 2012; Mausbach et al., 2010). Carotid plaques were more prevalent 
in caregivers (Roepke et al., 2011a), although caregiving duration did not predict carotid 
plaques (Roepke et al., 2012). Soluble intercellular adhesion module-1, a marker for 
cardiovascular risk, was reduced three months following the death of a spouse with dementia 
(Von Känel et al., 2012c). 
There were a number of moderating factors, including gender, on response to acute stress 
(Atienza et al., 2001; Thompson et al., 2004), and on a composite measure including BP, lipids, 
BMI, insulin and glucose (Zhang et al., 2006) as well as on DBP (Mills et al., 2009) and D-
dimer (Mills et al., 2009), though this was not the case for ambulatory HR or BP (Atienza et 
al., 2001). There was mixed evidence on ethnicity (Knight et al., 2007; Knight and McCallum, 
1998; Wilcox et al., 2005). Psychological factors moderating the impact of caregiver stress 
included higher engagement in pleasant events and reduced perceived activity restriction 
(Chattillion et al., 2013), closer affective bonds (Uchino et al., 1994), higher coping self-
efficacy (Harmell et al., 2011), active coping (Kim et al., 2007) and negative life events (Von 
Känel et al., 2003). Relationship with the care recipient moderated DBP and HR in the presence 
of the care recipient (King et al., 2002a). Sleep behaviour was associated with heightened D-
dimer (Mausbach et al., 2006), but not with hypertension (Schwartz et al., 2013). 
Cardiovascular disease (Vitaliano et al., 1998b), and lower levels of physical activity (Von 
Känel et al., 2011b) also moderated caregiver effects, but not genotype (Kring et al., 2010). 
In summary, there is mixed evidence concerning differences between caregivers and non-
caregivers in heart rate and systolic/diastolic BP, although mean arterial pressure does appear 
to be elevated in caregivers. There is evidence that D-dimer is elevated, and this effect appears 
to be due to anxiety and depression. A number of other cardiovascular indices have been 
measured but have yet to be replicated; further research into heart rate variability over the 
course of the day may yield greater insight into whether and in what ways heightened stress in 
caregivers manifests at a cardiovascular level. 
3.1.4. Dementia caregiving, epinephrine and norepinephrine 
Seventeen non-interventional articles examined epinephrine/norepinephrine (EPI/NE) levels 
in dementia caregivers (see Table 4). EPI and NE increased over time in caregivers along with 
stress (Clark et al., 2007), and duration of care was a predictor of EPI but not NE in caregivers 
(Ho et al., 2014). Caregivers with high life stress had higher NE (Mills et al., 1997) and 
caregivers identified as vulnerable had higher EPI than non-vulnerable caregivers (Mills et al., 
1999). However, caregivers did not differ from non-caregivers in EPI or NE in five other 
studies (Cacioppo et al., 2000; Irwin et al., 1991; Irwin et al., 1997; Malarkey et al., 1996; 
Redwine et al., 2004). 
A speech stressor increased EPI and NE in dementia caregivers (Adler et al., 2002), 
depression in caregivers predicted NE change in another study (Mausbach et al., 2005), and 
heightened anxiety and depression were associated with impaired recovery in NE (Aschbacher 
et al., 2008). ADL levels were associated with increased NE reactivity to a speech stressor 
(Roepke et al., 2008).  
A longer time caregiving was associated with higher NE and EPI in caregivers with lower 
leisure satisfaction (Chattillion et al., 2012). Increased waking after sleep onset was associated 
with heightened NE in caregivers (Mausbach et al., 2006). 
3.1.5. Dementia caregiving, neurocognition and neurotrophins 
Ten articles examined cognitive performance or neurotrophins in dementia caregivers (see 
Table 5). Three of these (Caswell et al., 2003; Vitaliano et al., 2007; Vitaliano et al., 2009) 
described poorer performance in caregivers on the digit symbols test, an assessment of speed 
of information processing and complex attention (Wechsler, 1981). Caregivers performed more 
poorly at an attention test (Attention Network Test) in another study (Oken et al., 2011) and 
had poorer executive function, as indicated by Trail Making B (Correa et al., 2015), and by 
Stroop performance in another (Oken et al., 2011). Working memory performance was 
worsened in caregivers (as assessed with digit span; Correa et al., 2015). Recall was worsened 
in caregivers (de Vugt et al., 2006; Palma et al., 2011) but not in another study after controlling 
for covariates (Correa et al., 2015), while other research found that recall was enhanced for 
emotive stimuli (Palma et al., 2011). There also was evidence of poorer performance on an 
embedded figures tests, and trends for poorer performance on a proofreading test (Burns et al., 
2002) and cognitive flexibility (de Vugt et al., 2006). 
Findings on neurotrophins were mixed; Correa et al. (2015) observed lower brain-derived 
neurotrophic factor (BDNF) in dementia caregivers, while Hadjiconstantinou et al. (2001) 
observed increased nerve growth factor (NGF). Although PET has been used to examine the 
impact of an intervention within dementia caregivers (see section 3.2 on intervention for 
caregivers), there has been a lack of brain imaging studies comparing caregivers to non-
caregivers. 
In summary, the most consistent findings on neurocognitive performance in caregivers are 
those suggesting poorer attention and executive function; findings on memory performance are 
more mixed, which may be due to differently valenced stimuli. Although research on 
neurotropins in caregivers has been mixed, only a very small number of studies have examined 
this, and further research in this area examining levels of caregiver stress more closely is 
warranted.  
3.1.6. Dementia caregiving and other biomarkers 
Dementia caregivers did not differ significantly in BMI (Aschbacher et al., 2007; Bauer et 
al., 2000; Bauer et al., 2001), or in glucose (Brummet et al., 2005) although they had heightened 
glucose, insulin and obesity in another study (Vitaliano et al., 2005). Males had higher BMI at 
baseline and follow-up, and although female caregivers did not have higher BMI they gained 
more weight between baseline and follow-up (Vitaliano et al., 1996a). Higher hostility was 
associated with higher glucose (Vitaliano et al., 1996b), and psychological distress was 
associated with higher glucose and mediated higher insulin at follow-up (Vitaliano et al., 
1996c). A higher sense of coherence was associated with reduced glucose levels in males, 
although caregiver status did not moderate this effect (Zhang et al., 2001). Caregivers did not 
differ in glycosylated hemogloblin concentration (Brummet et al., 2005).  
Caregivers have been found to have shorter telomere lengths (an index of cell ageing) in 
peripheral blood mononuclear cells (PBMC) (Kiecolt-Glaser et al., 2011), and caregivers had 
higher basal telomerase activity in PBMC and T cells (Damjanovic et al., 2007). However, 
another study did not find an effect on telomere length (Tomiyama et al., 2012).  In response 
to an acute stressor, there was a trend for reduced telomerase activity overall, but similar levels 
of reactivity (Epel et al., 2010).  
Reduced percentage sleep has been observed in caregivers (Von Känel et al., 2010a), although 
an overall difference in sleep efficiency was not observed between caregivers and non-
caregivers (Roepke et al., 2011a; Sakurai et al., 2015). In contrast, caregivers spent more time 
in sleep stage N1, but more in stage R, indicating less restorative sleep (Fonareva et al., 2011). 
Males caring for spouses with more severe dementia had more time awake after sleep onset 
and a trend for poorer sleep efficiency than female caregivers caring for spouses with more 
severe dementia (Mills et al., 2009). Spousal death in caregivers was associated with increased 
waking after sleep onset, increased daytime total sleep time and reduced night time percent 
sleep (Von Känel et al., 2012a).  
Female caregivers had lower skin temperature at pre-stress baseline and at post-stressor 
relaxation compared to males (Thompson et al., 2004). Glomerular filtration rate (a marker of 
kidney function) did not change in caregivers at follow-up, although it fell disproportionately 
after placement of spouse in a nursing home (Von Känel et al., 2012b).  Caregivers had lower 
levels of plasma tryptophan (a precursor of serotonin, as well as other neuroactive metabolites 
along the kynurenine pathway), although this finding was not statistically significant (Da Roza 
Davis and Cowen, 2001).  
Overall, there is some mixed evidence for metabolic syndrome biomarkers in caregivers, such 
as insulin and obesity, and they may only be heightened where distress is more substantial. 
Where there is a lack of difference in overall sleep, this may mask differences in sleep quality, 
and gender may moderate some sleep differences in caregivers. There is mixed evidence on 
telomere length in caregivers, and although other biomarkers of stress have been examined, 
further research would be required to establish the reliability of these effects. A summary of 
differences between caregivers and control participants in these biomarkers is provided in 
Table 6. 
3.2. Impact of dementia caregiving interventions on biomarkers of stress 
Eighteen studies have examined the impact of interventions on stress biomarkers (see Table 
7). Some of these have examined the effect of meditation or yoga on stress biomarkers: three 
have examined Kirtan Kriya, which enhanced executive function (Lavretsky et al., 2013) and 
memory, as well as reducing SBP (Innes et al., 2012) and altering genes bearing NF-κB- and 
IRF-1-response elements (Black et al., 2013). One study examined yoga & compassion 
meditation, which reduced cortisol (Danucalov et al., 2013). Another study indicated that 
transcendental meditation increased response speed (Leach et al., 2015). Mindfulness-based 
CBT improved attention but did not affect cortisol (Oken et al., 2010). In another study 
kundalini yoga affected numerous brain regions, assessed with PET (Pomykala et al., 2012).  
Cognitive behavioural therapy has also been shown to enhance cognitive performance in 
caregivers (Mackenzie et al., 2013), although there is mixed evidence on cortisol (Aboulafia-
Brakha et al., 2014; Vedhara et al., 2003). CBT enhanced IgG response (Vedhara et al., 2003), 
although combined psycho-education and CBT showed differing trends at post-intervention 
and follow-up (Wilkins et al., 1999). 
A respite intervention reduced EPI but did not affect NE, BP or HR (Grant et al., 2003). A 
“coping with caregiving” program corrected dysregulation in cortisol, but only in caregivers 
living with the care recipient and providing longer hours of care per day (Holland et al., 2011). 
An eight-week support program led to stable NE in comparison to an increase in the control 
group (Kim, 2011). A pleasant events program led to a reduction in IL-6 (Moore et al., 2013). 
A video-based coping skills intervention reduced BP, but did not alter BP or HR reactivity to 
acute stress (Williams et al., 2010). An exercise intervention reduced BP reactivity to acute 
stress (King et al., 2002b). 
Eight studies employed active control conditions (two psycho-education/information support, 
one psychological/information support plus community services, two relaxing music, one 
relaxation, one telephone support, one nutrition education), five employed a waitlist/no-
treatment control group, one employed both psycho-education support and respite-only control 
conditions, while four had no control group. 
In summary, the most consistent effects of the numerous interventions for caregivers 
examined appears to be an improvement in cognition. Other biomarkers, such cortisol and 
immune system factors have also been examined, but this latter body of evidence is less clear.  
3.3. Quality assessment 
A large majority of studies were rated as having low, low-moderate or moderate bias overall. 
With regard to sample selection, it should be noted that a number of longitudinal studies have 
led to the publication of numerous research articles, describing different biomarkers of stress 
within an overlapping cohort. Most studies reported their inclusion/exclusion criteria. A 
majority of studies controlled for at least three confounding variables. A majority also reported 
the duration of care and/or hours per week spent providing care, although there was some 
variability in the amount of hours per week spent caregiving (including minimum number of 
hours required for inclusion in research), and only a minority of studies indicated levels of 
ADL assistance provided. With regard to statistical analysis, few papers indicated a power 
analysis to outline whether the study was well-powered to detect expected effect sizes. A 
summary of the quality assessment is presented in Table 8. 
 
Discussion 
This systematic review summarises available data on a broad range of biological and 
cognitive markers of stress in informal dementia caregivers. The most consistent finding was 
that dementia caregiving was generally associated with greater HPA axis activity, as indicated 
by elevated cortisol levels (see Graphical Abstract). This HPA axis hyperactivity was 
documented using a variety of methodological approaches in different types of biological 
samples  and was apparent at single time points, in the cortisol awakening response and across 
the diurnal cycle of cortisol secretion. The impact of sustained HPA axis hyperactivity is well 
documented and has been implicated in the neurobiology of stress-related disorders such as 
depression (e.g. Otte et al, 2016). Further work is needed to assess the particular aspects of the 
caregiver experience that may moderate the biological impact of caregiver stress (e.g. 
challenging behaviours, duration of caregiving, relationship with care recipient), to determine 
if it is subgroup specific and to determine the best approach to managing any long-term 
physiological risks of caregiver stress.  
Chronic exposure to stress hormones like cortisol during adulthood and aging can have an 
impact on brain structures involved in cognition (Lupien et al., 2009). It is unsurprising then 
that there is good evidence to support a cognitive neurobiology of caregiving associated most 
robustly with poorer performance on attention tasks and executive function performance, 
although it should be noted that the size of these effects are relatively modest; computerised 
tasks that can measure performance (e.g. accurate measurement of reaction time) will thus be 
more sensitive to such effects. The observed impact upon cognition suggests that there is a 
functional consequence of the reported HPA axis hyperactivity; this is concerning, given that 
caregiving for a person with dementia can involve cognitively challenging tasks. This is also 
consistent with reports of impaired cognitive performance in other stress related disorders such 
as depression (e.g. Beck, 2008) and irritable bowel syndrome (Kennedy et al., 2014, 2015).  
Interestingly, our systematic analysis also indicates that interventions to reduce stress, 
including meditation as well as cognitive behavioural therapy, can improve cognitive 
performance (see Graphical Abstract). Unfortunately, the evidence regarding the impact of 
these interventions on cortisol levels are mixed and, based on the studies assessed here, it is 
unclear if the improvement in cognition is consistently linked to a blunting of the excessive 
HPA axis activity. Although pharmacological options targeting cortisol production are 
available, we note that this approach has not yet yielded impressive results in disorders such as 
depression (McAllister-Williams et al., 2016), although the populations under assessment are 
not always enriched for subjects with evidence of a HPA axis abnormality. In any case, it is 
premature based on the current analysis and in the absence of experimental validation of 
cortisol as a state or trait biomarker to advocate such an intervention. In this regard, we note 
the emerging support for the role of the gut microbiome in regulating HPA axis activity (Dinan 
& Cryan, 2012) and the recent demonstration that this might be achieved via the use of 
psychobiotics (Allen et al., in press) 
Activation of the immune system is associated with stress and has been linked to the 
emergence of psychopathology, making the assessment of immune function a logical target 
(Dantzer et al., 2008). In dementia caregivers however, there was mixed evidence. These 
disparate findings for the plethora of neuroimmune factors assessed make it difficult to difficult 
to draw firm and meaningful conclusions. The broad range of variables assessed using multiple 
methodologies and without a sustained focus on specific targets likely contributes to this 
uncertainty. In fact, there was stronger evidence for a reduced immune   response to various 
challenges than a baseline alteration in immune function from the analysis of circulating 
cytokines with additional reports of enhanced sensitivity to glucocorticoid challenge. The 
reduced ability to mount an appropriate immune response is an obvious concern in this 
population (Kiecolt-Glaser et al., 1991).  
 Although sustained elevations in circulating glucocorticoids might be expected to be 
immunosuppressive, this caregiver immune profile is at odds with that presented in depression, 
with evidence of immune system activation despite excess cortisol concentrations (c.f. review 
by Pariante & Lightman, 2008). This illustrates that the timing and duration of HPA axis 
dysfunction can have diverging physiological manifestations. We should also note that there 
was also evidence of an enhanced immune response and low grade immune system activation 
in some caregiver studies. Future studies need to determine if this is specific to any particular 
subgroup of caregivers.  
Taken together, these findings highlight risks to caregivers, as well as potential for 
intervention. Chronic excessive secretion of cortisol has been linked with numerous health 
problems, including hypertension and depression (e.g. Chrousos & Gold, 1998; Scott & Dinan, 
1998). If the immune system is subjugated in response to challenge, then caregivers may 
experience greater adverse health events from infection (Kiecolt-Glaser et al., 1991). 
Caregiving for a person with dementia can involve cognitively challenging tasks (e.g. 
managing difficult behaviours), so findings of reduced attention and executive function 
performance are of concern, but evidence that such differences can be attenuated by 
interventions to manage stress is promising. 
Longitudinal studies that track caregivers over time would be an informative approach but 
relatively few studies of this nature exist; assessment of caregivers as patients’ dementia 
progresses allows researchers to build bio-psychosocial profiles of any accumulating effects of 
increasingly severe chronic stress. It is worth considering that many dementia caregivers may 
not approach health services until they have been providing care for some time, and so a 
baseline measurement may not be feasible unless ageing participants are tracked prior to any 
manifestation of memory problems in the care recipients, or at least prior to memory problems 
necessitating the provision of care. Increases in problematic behaviours in care recipients are 
particularly relevant, as these have been shown to be more predictive of caregiver burden than 
reductions in cognitive capacity in the care recipient (Bédard et al., 1997). Linking the 
appearance of these problematic behaviours and the associated increase in caregiver burden to 
a particular biomarker signature or to the emergence of biological abnormalities would be a 
major advance. 
The majority of studies examining the impact of dementia caregiving stress used non-
caregivers as a control group, as opposed to caregivers for patients with a different condition 
or professional caregivers. There was heterogeneity in the comparison groups used to evaluate 
the specific impact of the interventions, although the most commonly employed approach was 
an active control group. Interventional research has indicated that meditation or yoga have the 
potential to improve cognitive performance in dementia caregivers, although some of these 
studies have small sample sizes (including a study examining the impact of yoga on brain 
activity using PET; Pomykala et al., 2012). Mindfulness-based interventions may be useful in 
targeting traits such as emotional intelligence and anxiety sensitivity, which may impact upon 
stress reactivity (Choi et al., 2014), although emotional cognition also remains an under-studied 
aspect of cognition within this area. 
Studies in this area comparing dementia caregivers to a control group generally used non-
caregivers as a control group. Given previous evidence that dementia caregivers experience 
greater stress than other informal caregivers, it would be of interest if stress biomarkers also 
differ in a graded fashion between these groups. It would also be of interest to compare family 
caregivers to professional caregivers, to understand the impact the stress of a loved one having 
dementia in addition to caring for them, although caring self-efficacy may be considerably 
lower in family caregivers who are not familiar with dementia or are still learning how to deal 
with the challenges of providing care. 
For the majority of studies, the mean age of participants was over 60 years of age, and so the 
compounding interaction between aging and the chronic stress of dementia caregiving needs 
to be considered. This should also be evaluated against the studies that also included caregivers 
below this age range. Although the majority of dementia carers are women (Prince et al., 2015), 
the research examined here was not restricted to females, and has indicated the impact of 
dementia caregiving on biomarkers of stress (e.g. immune system activity) may be moderated 
by gender. The moderation of stress biomarkers by characteristics of the caregiver is important, 
given that a systematic review has suggested that the characteristics of caregivers may be a 
better predictor of patient institutionalisation than the behavioural and psychological symptoms 
of dementia (Black and Almeida, 2004). 
Risk of bias was generally low to moderate. Strengths of the studies reviewed included the 
fact that most controlled for potential confounders (e.g. age, gender, income), and the studies 
were generally transparent about their inclusion/exclusion criteria. However, there were 
weaknesses as well. Many of the studies did not report effect sizes for observed effects. 
Although laboratory procedures for processing biomarkers are generally reported, a number of 
studies analysing a particular analyte have collected samples in a way which could reduce 
comparability between studies (e.g. salivary cortisol being collected at different times of day, 
lack of standardisation in assays). A number of papers report on measures statistically 
integrating multiple biomarkers to form composite measures of cardiovascular risk or allostatic 
load. Caution should be used in comparing such measures across studies, given that the score 
will be affected by the nature and number of biomarkers measured, as well as the method of 
assessment. 
Our key methodological recommendations for future research are thus as follows: (i). further 
prospective/longitudinal designs to allow for greater understanding of the impact of the chronic 
stress of caregiving over time, (ii). clear reporting of effect sizes and assay techniques, (iii). 
better-powered intervention studies with well-defined comparison groups, (iv). the assessment 
of multiple biomarkers of stress within caregiver studies, to allow for associations between 
different biomarkers to be studied within individuals, (v). detailed phenotyping of caregivers, 
including better characterisation of the duration and intensity of caregiving, as well as the 
numerous other factors that can moderate the impact of dementia caregiving on stress 
biomarkers. 
There are a number of different biological and neurocognitive factors that remain unexplored 
in dementia caregivers. Despite research interest in cognitive performance in this group, brain 
imaging techniques have had very limited use in research on dementia caregivers; one study 
has examined the impact of an intervention for caregivers using PET. Polysomnography, which 
incorporates EEG has been employed, but only to study sleep architecture as opposed to 
neurocognitive performance. fMRI could be an informative means of examining the underlying 
neurocognitive impact of stress in dementia caregivers, and would be less invasive than PET. 
Given findings that caregivers have poorer performance on tests of attention, it is of interest to 
determine the impact that the stress of dementia caregiving has on frontal cortex function. 
Similarly, findings of impaired executive function suggest that the anterior cingulate cortex 
may be implicated in the impact of caregiver stress upon cognition.   
Although research on cognition in dementia caregivers has focused on memory, attention and 
executive function, there is more scope for examining complex cognition in caregivers. As 
caregivers frequently make decisions for the people that they care for, and as informal 
caregivers can often experience financial difficulty, it would thus be of interest to examine 
decision making in caregivers, such as the use of heuristics in financial decision-making. 
Problem solving could be examined in greater depth, as problem-focused coping may be a 
healthier approach to dealing with the challenges of providing care. 
The microbiota is a promising future direction for the examination of the psychobiology of 
caregiver stress, and perhaps of chronic stress more broadly. There is existing evidence that the 
microbiota is altered in the stress-related gastrointestinal disorder irritable bowel syndrome 
(Jeffery et al., 2012), which is more prevalent in caregivers of people with chronic illnesses 
(Remes-Troche et al., 2015). Microbiota analysis which follows caregivers prospectively may 
establish if chronic stress effects are mediated by the microbiota, or indeed if existing changes 
in the microbiota may be a risk factor for more pathological effects of chronic stress.  
We should not ignore that in addition to being stressful, caregiving can be highly rewarding 
(Boerner et al., 2004; Tarlow et al., 2004), and the potential negative physiological effects of 
dementia caregiving can be offset by factors such as high levels of self-efficacy (Harmell et 
al., 2011). Nevertheless it is clear there is a high potential for a widespread detrimental 
psychobiological impact of caregiving and all relevant stakeholders in the healthcare process 
need to be cognisant of this for informed management strategies. Further research in this area 
should help us to better understand what protective factors and targeted interventions can 
minimise the impact of stress in caregivers for people with dementia, who play a vital role 
within our society.  
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Figure 1: Flow chart of study literature search with reasons for exclusion 
 
Table 1: Summary of studies examining effects of family dementia caregiving on HPA axis activity 
Article Sample size Participant age, gender & 
ethnicity 
Relation to care 
recipient 
Level of care 
provided 
Biomarkers 
examined 
Findings  
Aschbac
her et al. 
(2013)  
-CG: N = 25 
-Non-CG: N = 
23  
Mean age: 63, range = 51-79  
All female 
43 Caucasian, 4 Asian/Pacific 
Islander, 1 African-American  
 
 
- Mean duration = 
4.7 years, range = 
8 months - 11.42 
years 
 
Salivary cortisol  
 
CG: ↑ perceived stress associated 
with greater anticipatory and peak 
cortisol reactivity to acute stressor.  
Non-CG: perceived stress: not 
associated with peak or 
anticipatory cortisol. 
Bauer et 
al. (2000) 
-CG: N = 49 Mean age = 72, SD = 7.7  
F = 24, M = 25  
All Caucasian  
All spouses - Salivary cortisol 
 
Elderly CG: ↑ distress and ↑ 
salivary cortisol 
Brummet 
et al. 
(2008) 
-CG: N = 42 
-Non-CG: N = 
32 
- CG: Mean age = 70.1, SD = 13.6 
80.9% Caucasian, 19.1% African-
American 
- - Urinary cortisol CG (but not non-CG) with less 
active MAOA-uVNTR genotype 
did not show enhanced cortisol 
-Non-CG: Mean age = 66.1, SD = 
14.1  
78.1% Caucasian, 21.9% African-
American 
All male  
output at daytime compared to 
overnight 
 
Caciopp
o et al. 
(2000) 
-CG: N = 27 
-Non-CG: N = 
37 
Mean age = 67.17, SEM = 1.03 
83% White, 17% Black 
All female 
All spouses Mean level = at 
least 5 hours/week 
Plasma cortisol, 
ACTH 
CG: higher plasma ACTH. CG 
showed larger increase in cortisol 
in response to stress 
Clark, et 
al. (2007) 
At Yr 1: New 
CG: N = 80  
-Veteran CG: 
N = 120   
-Non-CG: N = 
60.  
 
-New CG: Mean age = 73.9, SD = 
7.1 
62.5% female 
-Veteran CG: Mean age = 74.2, SD 
= 7.4 
65.8% female 
-Non-CG: 71.9, SD = 7.7 
68.2% female 
All spouses -New CG: Mean 
duration = 5.4 
months, SD = 3.  
-Veteran CG: 
Mean = 39.7 
months, SD = 17.9 
Urinary cortisol,  
EPI 
NE  
serum DHEA-S 
(primary 
mediators) 
Primary mediators significantly 
associated with stress- ↑ with time 
for CG but not non-CG 
Correa et 
al. (2015) 
-CG: N = 17  
-Non-CG: N = 
18  
-CG: Mean age: 64.83, SEM = 
3.64  
F = 13, M = 5 
-Non-CG: Mean age = 58.29, 
SEM = 3.16  
F = 14, M = 3 
- 
- Duration: at least 
one year  
Level: at least 8 
hours per day  
Saliva cortisol 
and DHEA 
 
CG: ↑ cortisol/DHEA ratio 
 
Da Roza 
Davis et al. 
(2001) 
-CG: N = 30 
-Non-CG: N = 
28 
-CG: Mean age = 68.8, range = 
30-75 years  
F = 18, M = 12 
-Non-CG: Mean age = 68.1, 
range = 35-84 years  
F = 17, M = 11 
-  
- - Saliva cortisol 
(8.00, 12.00, 
16.00, 22.00),  
 
Higher cortisol in CG (at 12.00 and 
22.00) 
Davis et 
al. (2004) 
-CG: N = 30  Mean age = 76.9, SD = 6.9 
All female 
76.7% Caucasian, 23.3% African-
American 
 
All spouses Mean duration = 
69 months, SD = 
28.9 
Mean level: 11.6 
hours/day, SD = 
6.9   
 
Salivary cortisol ( 
4 times beginning 
2h after arising 
and ending 2h 
before their 
reported time of 
retiring for the 
night) 
CG events: ↑ Cortisol production  
 
De Vugt 
et al. 
(2005) 
-CG: N = 57 
-Non-CG: N = 
55  
-CG: Mean age = 60.4, range = 
34-81  
F = 36, M = 21 
-Non-CG: Mean age = 60.5, 
range = 31-85  
F = 36, M = 19 
- 
28 spouses, 26 
children, 3 other 
Mean duration = 
31.1 months 
(range = 3-120 
months) 
Mean level = 85.6 
hours per week 
(range = 2-168) 
 CG: ↑ cortisol at awakening, with 
smaller ↑ after awakening. Higher 
cortisol awakening response in CG 
of patients with ↑ behavioral and 
psychological symptoms of 
dementia (BPSD) 
Epel et 
al. (2010) 
-CG: N = 22 
-Non-CG: N = 
22 
Mean age = 62, range = 51-75  
All female  
 84% Caucasian, 5% African 
American, and 11% Asian 
 
 
All spouses/ 
partners 
Level: at least 4 
hours/day 
Salivary cortisol 
(in response to 
stressor)  
CG had similar baseline cort levels 
and peak cortisol reactivity, but 
earlier onset of cortisol reactivity 
Fonareva 
et al. 
(2011) 
-CG: N = 20 
-Non-CG: N = 
20 
-CG: Mean age = 64.5, SD = 7.13  
F = 18, M = 2 
-Non-CG: Mean age = 66.95, SD = 
7.89 
F = 18, M = 2 
97.5% White 
 
70% spouses, 
30% children 
- Salivary cortisol 
(bedtime, waking, 
30 minutes post 
waking),  
 
CG: ↑ salivary cortisol at waking 
only 
 
Gallaghe
r-
Thompson 
-CG: N =83 
-Non-CG: N = 
39 Subsample of 
-CG: Age range: 40-70 years 
20 Hispanic and 24 non-Hispanic 
white  
- - Salivary cortisol 
three saliva 
samples daily for 
CG: ↑ 8 AM, 5 PM, and 9 PM 
cortisol. Both ethnicity and 
depressive symptoms 
et al. 
(2006) 
17 Hispanic and 
28 non-Hispanic 
white 
participants 
matched on age 
and education 
used for main 
analyses. 
-Non-CG: 19 Hispanic and 20 
non-Hispanic white 
All female 
3 consecutive 
days. 
independently predicted daytime 
cortisol slope. 
Holland 
et al. 
(2010) 
-CG: N = 47 
  
Mean age = 59.5, SD = 12.8 
Female 
Chinese 
 
54.5% Daughter, 
38.6% spouse, 
6.8% daughter-in-
law 
 
Duration = About 
4 years 
Mean level = 9.8 
hours/day, SD = 
7.9  
Salivary cortisol 
(wake, 5pm, 9pm) 
 
Belief in Asian values predicted 
cort: ↑ cortisol at wake: steeper 
descent (i.e. less dysregulated) 
 
Irwin et 
al. (1997) 
-CG: N = 100 
-Non CG: N = 
33 
-CG: Mean age = 71, SD = 7.2 
F= 57%, M= 43% 
All spouses 
 
Mean duration = 
2.1 years, SD = 
1.2 
Plasma ACTH, 
cortisol 
 
CG: no difference in ACTH, 
cortisol. Dementia severity did not 
87% White, 4% Black, 5% 
Hispanic, 4% Asian 
-Non-CG: Mean age = 69.6, SD 
= 6.2 
F = 58%, M = 42% 
100% White 
predict cortisol. Demand/respite 
mismatch predicted ACTH only 
Jeckel et 
al. (2010) 
-CG: N = 41 
-Non-CG: N = 
33 
-CG: Mean age = 60.56, SD = 
16.56.  
F = 32, M = 9 
-Non-CG: M = 60.27, SD = 14.1  
F = 26, M = 7 
- 
All spouses Mean duration = 
4.03 years, SD = 
2.89 
Mean level = 16 
hours/day, SD = 
5.73 
Salivary cortisol 
& DHEA-S (8.00, 
12.00, 20.00), 
HPA response to 
dexamethasone 
suppression test 
(DST) 
CG: ↓ cortisol at 8.00, ↓ DHEAS 
& ↑ cort/DHEAS. More cortisol 
non-suppressors among CG in 
response to DST. 
 
Klein et al. 
(2014) 
-CG: N = 158 Mean age = 61.59, SD = 10.54 
F = 87.3% 
74.1% White 
58.2% children, 
38% spouses 
 
Mean duration = 
62.05 months,  SD 
= 46  
Salivary cortisol 
(wake, wake + 30 
minutes, before 
CG with negative CAR on non-
ADS days had positive CAR on 
ADS days, CG with flat CAR or 
  
lunch, before 
dinner, before 
bed)  
 
medium-high CAR on non-ADS 
days had increased CAR on ADS 
days, and CG with high CAR on 
non-ADs days had reduced CAR 
on ADS days (similar pattern for 
AUCg data) 
Leggett et 
al. (2014) 
-CG: N = 164 
 
-CG: Mean age = 61.79, SD = 
10.47  
F = 87.2% 
72.6% White, 25,6% African 
American, 1.8% Other 
 
38.4% spouses, 
57.3% children, 
4.2% other 
 
Mean duration = 
61.56 months, SD 
= 46.2 
CAR 
Cortisol area 
under the curve 
with respect to 
ground (AUCg) 
↑ anger scores on days when 
AUCg below average  
Model 2: anger associated with ↑ 
care-related stressors, not with 
ADS use or daily cortisol. 
Depressed mood associated with 
more care-related stressors and a 
low average CAR. 
Malarke
y et al. 
(1996) 
-CG: N = 10 
-Non-CG = 16 
(10 completed 
acute stressor, 6 
did not) 
Mean age = 69 
All female 
- 
All spouses - Plasma cortisol, 
ACTH 
CG: ↑ ACTH. CG: no difference in 
cort. CG did not differ in stress 
response on these variables 
McCallu
m et al. 
(2006) 
-CG: N = 54  
-Non-CG: N = 
63 
-CG: African-American: Mean 
age = 58.17, SD = 8.3, European 
American: Mean age = 67.5, SD = 
10.95 
30 African American and 24 
European American 
-Non-CG: African-American: 
Mean age = 59. European 
American: Mean age = 71  
48 AA, 15 European American 
All female 
AA: 66% 
children, 16% 
spouses, 
European: 25% 
children, 75% 
spouses 
 
Level: At least 
10 hours/week 
Salivary diurnal 
cortisol  
Participants also 
collected five 
saliva samples 
daily for two 
consecutive days 
Only age and ethnicity predicted 
cortisol slope  
Merritt & 
McCallum 
(2011) 
-CG: N = 54 
-Non-CG: N = 
63 
-CG: African-American: Mean age 
= 58.2, SD = 8.3, White: Mean age 
= 67.2, SD = 10.2 
-Non-CG: AA: Mean age = 59  
White Mean age = 71 
All female 
-CG: 30 African-American, 24 
White, -Non-CG: 48 African-
American, 15 White 
-AA: 67% 
children,  
-White: 26% 
children 
 
-AA: Mean 
duration = 60.13 
months, SD = 
54.38,  
-White: Mean 
duration = 70.39, 
SD = 31.2 
Level: at least 10 
hours/week 
 
Saliva cortisol 
(wake, 9am, 
12noon, 5pm 
9pm) 
 
John Henryism coping associated 
with flatter cortisol slope. For high 
JHAC AA, CG status predicted 
flatter cortisol slope.  
Merritt & 
McCallum 
(2013) 
-CG: N = 30 
-Non-CG: N = 
48 
-CG Mean age: 58.2, SD = 8.3 
-Non-CG: Mean age = 59.6, SD = 
10.7 
All female 
All African-American 
67% children Mean duration = 
60.1 months, SD = 
54.4 
Level: at least 10 
hours per week 
Saliva cortisol 
(wake, 9am, 
12noon, 5pm 
9pm) 
 
↑ religious coping = flatter cortisol 
slope (specifically at higher 
memory/behaviour problems)  
 
Mills et 
al. (1997) 
-High stress 
CG: N = 10  
-Low-stress 
CG: N = 17 
-Non CG: N = 
10  
-High stress CG: Mean age = 72, 
SD = 5  
F = 8, M = 2 
-Low stress CG: Mean age = 75, 
SD = 7 
F = 13, M = 4 
-Non-CG: Mean age = 74, SD = 
7 
F = 2, M = 8 
- 
All spouses - Plasma cort CG with high life stress: no 
change in plasma cort. 
Neri et 
al. (2007) 
-CG (BPSD): 
N = 10 
-CG (hip 
fracture/HF): N 
= 10 
CG (BPSD): M = 60.6, SD = 7.9 
F = 8, M = 2 
CG (HF): M = 49, SD = 8.7 
F = 10 
CG (res): M = 56.9, SD = 4.6 
F = 8, M = 1 
- CG (BPSD): 
Mean duration = 
36.1 months, SD = 
23.5 
Salivary cortisol  
 
CG showed a reduction in cortisol 
(between 1 week from entry and 3-
7 days before discharge)  
-CG 
(respite/res): N = 
9 
- Mean level = 
10.7 hrs/day, SD = 
11.2 
CG (HF): Mean 
duration = 59.4 
months, SD = 71.1 
Mean level = 3.2 
hours/days, SD = 
2.1 
CG (res): Mean 
duration = 43.3 
SD = 38.4 
Mean level = 9.6 
hrs/day, SD = 4.6 
Oken et 
al. (2011) 
- CG: N = 31 -CG: Mean age = 64.5, SD = 9.3  
F = 25, M = 6  
23 spouses  Level: minimum 
10 hours/week 
Morning 
salivary cortisol 
CG: ↑ waking cortisol 
-Non-CG: N = 
25 
-Non-CG: Mean age = 66.5, SD 
= 7.6  
F = 22, M = 3  
(waking, prior to 
sleep) 
 
 
Palma et 
al. (2011) 
-CG: N = 14   
-Non-CG: N = 
24 
-CG: Age range = 66-74 
F = 7, M = 7 
-Non-CG: Age range = 61-82 
F = 20, M = 4 
- Duration: at least 
1 year 
Level: at least 6 
hours/day 
Salivary cortisol 
(8.00, 16.00, 
22.00) 
 
CG: ↑ cortisol at 22.00 but not at 
earlier times 
 
Stalder et 
al. (2014) 
 
-CG: N = 20 
-Non-CG: N = 
20 
-CG: Mean age = 71.2, SD = 6.1  
F = 19, M = 1 
-Non-CG: Mean age = 72.2, SD 
= 6.4  
F = 17, M = 3 
- 
20 spouses, 1 
child (1 excluded) 
 
Mean duration = 
40.8 months, SD = 
30.8 
Hair cortisol 
concentration 
(HCC) 
CG: ↑ HCC  
CG: trend for positive association 
of HCC with CG burden and 
positive association with 
depressiveness.  
Tarrier et 
al. (2002) 
-CG: N = 100 Mean age = 63.1 years, SD = 13.6 
F = 57, M = 43 
- 
53 spouses, 36 
children, 11 other 
Mean duration = 
35.2 months, SD = 
28.7 
Salivary cortisol 
(9.00a.m and 
Strain and distress associated with 
morning cortisol 
 
Mean level = 
56.1 hours/week 
(“face-to-face 
contact”), SD = 
30.5  
11.00pm for 3 
consecutive days) 
 
Tomiya
ma et al. 
(2012) 
-CG: N = 14 
-Non-CG = 9 
Mean age = 62, SD = 6.46 
All female 
82% White, 11% Asian, 5% Black, 
2% Latina 
All partners - Salivary cortisol 
(waking, 30 
minutes post-
waking, bedtime; 
urine over 12 hr) 
CG: no difference in cortisol 
 
Vedhara 
et al. 
(1999) 
- CG: N = 50 
-Non-CG: N = 
67  
-CG: Median = 73, interquartile 
range = 66-77  
F = 26, M = 24 
-Non-CG: Median = 68, 
interquartile range = 66-71 
F = 36, M = 31 
All spouses Mean duration = 
3.5 years, SD = 
2.7 
Salivary cortisol 
(between 8.00-
10.00/before 
breakfast, 11.00-
13.00/before 
lunch, 20.00-
CG: ↑ AUC for cortisol at baseline, 
3 months and 6 months.  
All Caucasian 
 
22.00/at least two 
hours after 
evening meal) 
Wahbeh 
et al. 
(2008) 
-CG: N = 15  
-Non-CG: N = 
15 
-CG: Mean age = 70, SD = 9  
F = 9, M = 6 
15 White 
-Non-CG: Mean age =75, SD = 5  
F = 10, M = 5 
14 White 
- - Salivary CAR 
Salivary diurnal 
cortisol 
CG: ↑ cortisol values. Unlike non-
CG, cortisol in CG ↑ between 
awakening and 30 minutes 
afterward 
Wilcox 
et al. 
(2005) 
-CG: N = 28  -Caucasian CG: N = 16, Mean 
age =65.69, SD = 10.5 
-African-American CG: N = 12, 
Mean age = 62, SD = 10.2  
All female 
 
-Caucasian CG: 
8 spouse, 8 
children 
-AA CG: 3 
spouse, 7 children, 
2 siblings 
-Caucasian CG: 
Mean duration = 
47.56 months, SD 
= 43.89 
Mean level = 
73.75 hours/week, 
SD = 56.65 
Salivary cortisol More AA (58%) than Caucasians 
(14%) showed cortisol reactivity 
from rest to 15-minutes post-
challenge. 
-AA CG: Mean 
duration = 60 
months, SD = 
40.97,  
Mena level = 
96.08 hours/week, 
SD = 42.54 
  
Table 2: Summary of studies examining effects of family dementia caregiving on the immune system 
Article Sample size Participant age, gender & 
ethnicity 
Relation to care 
recipient 
Level of care 
provided 
Biomarkers 
examined 
Findings  
Adler et 
al. (2002) 
-CG: N = 67 Mean age = 73, range: 56-82 
F = 45, M = 22 
88% Caucasian 
- - Total leukocytes 
Total 
lymphocytes 
 
Speech stressor ↑ circulating 
leukocytes, LFA-1 density, ↓ L-
selectin density. 
Aschbac
her et al. 
(2007)  
-CG: N = 51 
-Non-CG: N = 
27 
Mean age = 77, SD = 6.8 
All female 
95% Caucasian 
All spouses Mean duration = 
7.75 years, SD = 
2.49 
Platelet 
activation 
 
↑ platelet activation in CG's 
taking HRT. No main effect of CG 
on platelet activity.  
 
Aschbac
her et al. 
(2008) 
-CG: N = 39 
-Non-CG: N = 
31 
-CG: Mean age = 68.7, SD = 7.99  
F = 25, M = 14   
-Non-CG: Mean age = 71.87, SD 
= 7.07  
All spouses Mean duration = 
9 years 
Percent platelet P-
selectin (PSEL) 
CG: ↑ symptoms of depression 
and anxiety associated with ↑ 
PSEL reactivity, and delayed 
PSEL recovery. CG: Delayed NE 
F = 22, M = 9 
65 Caucasian 
 
recovery associated with ↑ PSEL 
reactivity and delayed PSEL 
recovery  
Aschbac
her et al. 
(2009) 
-CG:  N = 99 Mean age = 73 (range = 52-88) 
F = 68%, M = 32% 
93% Caucasian 
All spouses - PSEL ↑ depression significantly 
predicted ↑ PSEL activation by 
stressor 
 
Aschbac
her et al. 
(2013)  
-CG: N = 25 
-Non-CG: N = 
23  
Mean age: 63, range = 51-79  
All female 
43 Caucasian, 4 Asian/Pacific 
Islander, 1 African-American 
 
 
- Mean duration = 
4.7 years, range = 
8 months - 11.42 
years 
 
8-oxoG, 8-OHdG, 
IsoP 
 
CG: Perceived stress not 
associated with any oxidative 
stress markers. Non-CG: 
perceived stress: ↓ IsoP and trend 
to ↓ 8-oxoG and 8-OHdG. 
Bauer et 
al. (2000) 
-CG: N = 49 Mean age = 72, SD = 7.7  
F = 24, M = 25  
All Caucasian  
All spouses - Full blood count 
Lymphocytes 
Elderly CG: ↓ mitogen-induced 
lymphocyte proliferation, ↓ 
mitogen-induced IL-2 production, 
Glucocorticoid 
concentration 
IL-2 
and ↓ lymphocyte sensitivity to 
glucocorticoids 
Bristow 
et al. 
(2008) 
-CG: N = 25 
-Non-CG: N = 
36 
-CG: Mean age = 62.9, SD = 5.9  
F = 76%, M = 24% 
-Non-CG: Mean age = 63.3, SD 
= 5.4  
F = 69%, M = 31% 
- 
All spouses/ 
partners 
- Salivary 
immunoglobulin 
A (IgA) 
 
CG: no difference in IgA 
secretion 
Caciopp
o et al. 
(1998) 
- CG: N = 27 
-Non-CG: N = 
37  
Mean age = 67.17, SEM = 1.03  
All female  
83% White, 17% Black  
All spouses Level: at least 5 
hours/ week 
Blood percentages 
of T lymphocytes 
(CD3+), two 
subsets of T 
lymphocytes 
(CD4+ and 
CD8+), and NK 
CG: ↓ proliferative response to 
concanavalin A and a non-
significant ↓ in response to PHA. 
CG: ↓ percentage of NK cell 
cytotoxicity.  No interaction 
between CG status and acute 
stressor 
cells (CD56+), 
NK cell 
cytotoxicity., 
mitogen-
stimulated PBl 
activity 
 
Castle et 
al. (1995) 
-CG: N = 11 -CG: Mean age = 70, SD = 5.7  
All female  
- 
All spouses - Lymphocytes Depression strongest association 
with impaired T cell proliferative 
capacity. Depression was also 
most strongly associated with ↑ 
CD8+ T cells, and a reduced 
percentage of CD38+ cells in both 
CD8+ and CD4+ T cell 
populations. ↓ percentage of CD 
38+ cells correlated with impaired 
T cell function (proliferation). ↓ in 
natural killer (NK) cells and 
percentage of CD56+ component 
of the CD8+ population.  
Damjano
vic et al. 
(2007) 
-CG: N = 41 
-Non-CG: N = 
41 
Mean age = 65, SD = 1 
-CG: F = 30, M = 11 
-Non-CG: F = 30, M = 11 
 - 
26 spouses, 15 
children 
Mean duration = 
5.2 years, SD = 
0.5 
PBMC, T-cells & 
monocytes: 
cytokines (IL-2, 
IL-4, IL-6, IL-8, 
IL-10, GM-CSF, 
IFN-gamma, 
TNF-alpha)  
CG had lower T cell proliferation 
but higher production of immune-
regulatory cytokines (TNF-α and 
IL-10).  Percentage of T/B cells, 
monocytes and NK cells not sig. 
different for CG. 
Esterling 
et al. 
(1994) 
-CG: N = 14 
-Bereaved CG: 
N = 17 
-Non-CG: N = 
31 
-CG: Mean age = 68, SEM = 3.21 
F = 9, M = 5 
-Bereaved CG: Mean age = 72.3 
years, SEM = 2.06  
F = 12, M = 5 
Family -CG: Mean 
duration = 62.53 
months, SEM = 16 
Mean level = 5.08 
hour/day  
Peripheral blood 
leukocytes treated 
with rIL-2 and 
rIFN-gamma, NK 
cell and 
lymphokine-
Continuing and bereaved CG did 
not differ in NK response to rIL-2 
or rIFN-gamma; both worse NK 
response than non-CG.  
 
-Non-CG: Mean age = 70.9 
years, SEM = 1.82 
F = 22, M = 9 
94% White 
-Bereaved CG: 
Mean = 26.57 
months, SEM = 
3.09, since death 
of care recipient  
Mean level = 6.97 
hour/day.  
 
activated killer 
cells 
 
Esterling 
et al. 
(1996) 
-CG: N = 11 
-Bereaved CG: 
N = 17 
-Non-CG: N = 
29 
- CG: Mean age = 71.5, SEM = 
2.97  
F = 17, M = 4  
-Bereaved CG: Mean age = 61.9, 
SEM = 3.2  
F = 11, M = 6 
-Non-CG: Mean age = 68.9, SEM 
= 1.51 
Family members -CG: Mean 
duration = 9.6 
years.  
Mean level = 4.2 
hours/day. 
-Bereaved CG: 
Mean = 36.6 
months, SD = 4.46 
Enriched NK 
response to rIL-2 
or rIFN-gamma;  
 
CG (both groups): worse NK 
response in vitro to recombinant 
IL-2 or IFN-gamma, and worse 
response to cytokines.  
 
F = 22, M = 7 
90% Caucasian 
months since 
death of care 
recipient 
Fonareva 
et al. 
(2011) 
-CG: N = 20 
-Non-CG: N = 
20 
-CG: Mean age = 64.5, SD = 7.13  
F = 18, M = 2 
-Non-CG: Mean age = 66.95, SD = 
7.89 
F = 18, M = 2 
97.5% White 
 
70% spouses, 
30% children 
- CRP, IL-6, TNF-
alpha 
 
CG: ↑ CRP, no difference in IL-
6 or TNF-alpha 
Glaser et 
al. (1998) 
Vaccination 1:  
-CG = 23 
-Bereaved CG 
= 26 
-Non-CG = 27 
-CG: Mean age = 71.92, SEM = 
1.72  
-Bereaved CG: Mean age = 
72.65, SEM = 1.7  
-Non-CG: Mean age = 70.67, 
SEM = 1.83  
All spouses Bereaved CG: 
Mean = 23.84 
months, SEM = 
3.3 since death of 
spouse 
Antibody titres to 
influenza vaccine 
and PBL ability to 
synthesize IL-2 
 
CG (both groups): ↓ antibody titres 
to vaccine and more rapid ↓ in PBL 
ability to synthesize IL-2 after 
stimulation with Fluzone  
 
-  
-  
Glaser et 
al. (1998) 
Vaccination 2: 
-CG = 32 
-Bereaved CG 
= 22 
-Non-CG = 68 
-CG: Mean age = 73.12, SEM = 
1.53  
-Bereaved CG: Mean age = 
72.77, SEM = 1.82  
-Non-CG: Mean age = 71.54, 
SEM = 1.05  
- 
- 
All spouses Bereaved CG: 
Mean = 29 
months, SEM = 
3.81 since death of 
spouse 
Antibody titres to 
influenza vaccine 
and PBL ability to 
synthesize IL-2 
 
Fewer four-fold responders in 
CG's 
 
Glaser et 
al. (1997) 
-CG: N = 71 
-Non-CG: N = 
58 
-CG: Mean age = 60.55, SEM = 
1.52  
F = 58, M = 13 
-Non-CG: Mean age = 62.41, 
SEM = 1.98  
F = 45, M = 13 
34 spouses, 37 
children 
Mean duration = 
7.66 years, SEM = 
4.56 
Mean level = 
4.86 hours/day, 
SEM = 5.04  
Antibody titres to 
HSV-1, HSV-1 
virus neutralising 
antibody titres, 
HSV-1 specific T-
CG: ↑ antibody titres, no 
difference in neutralising 
antibody, ↓ proliferative response 
to HSV-1  
 
92% White cell proliferation 
response 
Glaser et 
al. (2000) 
-CG: N = 11 
-Bereaved CG: 
N = 13 
-Non-CG: N = 
28   
-CG: Mean age = 68.09, SD = 3.8  
-Bereaved CG: Mean age = 
72.46, SD = 2.29 
-Non-CG: Mean age = 69.54, SD 
= 1.69 
F = 39, M = 13 
84% White 
All spouses Mean duration: 
CG: Mean = 6.93 
years, SEM = 
0.94, Mean level = 
8.39 hours/day, 
SD = 1.98   
Bereaved: Mean = 
2.08, SEM = 0.5 
years since their 
spouse died 
 
IgC titres in 
response to 
vaccination 
 
CG: antibody titres ↓ over 6 
months, bereaved CG and non-CG 
remained the same 
Glaser et 
al. (2001) 
-CG: N = 16 
-Bereaved CG: 
N = 16 
-CG: Mean age = 71.69, SD = 
7.25  
All spouses Duration: CG: 
Mean = 104.11 
months, SEM = 
Cytoplasmic 
cytokines: cells 
synthesising IL-2, 
CG: ↑ percentage of IL-10 in PBL. 
No difference for cells expressing 
IL-2 or IFN-gamma.  
-Non-CG: N = 
44   
-Bereaved CG: Mean age = 77, 
SD = 9.51 
-Non-CG: Mean age = 69.89, SD 
= 9.26. 
71% female 
82% Caucasian, 18% African-
American 
12.31, Mean level 
= 7.6 hours/day 
Bereaved: Mean = 
2.57 years, SEM = 
0.5, since death of 
spouse 
 
IL-10+ T cells, 
intercellular IFN-
gamma. Percent 
and number of IL-
10/CD-4, IL-
10/CD-8, IFN-
/CD-4, IFN-/CD-
8 and IL-2/CD-4, 
and IL-2/CD-8 
cells 
 
Gouin et 
al. (2012) 
-CG: N = 53 
-Non-CG: N = 
77 
-CG: Mean age = 64.3, SD = 
11.17  
F = 79.25%, M = 21.75%. 
79.25% Caucasian 
-Non-CG: Mean age = 65.97, SD 
= 14.35,  
35 children, 18 
spouses 
Mean duration = 
56 months, SD = 
44  
Mean level = 
8.21 hours/day, 
SD = 7.92 
Serum IL-6, CRP 
 
CG: ↑ CRP, no difference on IL-6 
levels. Direct effect of CG status 
on CRP and mediating effect of 
daily stressors.  
 
F = 84.41% M = 15.59% 84.41% 
Caucasian 
Graham 
et al. 
(2006) 
-CG 
(continuing & 
bereaved): N = 
113 
-Non-CG: N = 
101 
-CG: Mean age = 69.8, SD = 9.5  
F = 69%, M = 31% 
90.3% Caucasian 
-Non-CG: M = 68.2, SD = 9.5 
F = 74%, M = 26%  
84.2% Caucasian 
All spouses Level: At least 5 
hours/week at 
inclusion 
Plasma IL-6 and 
CRP 
 
In structural equation models, path 
between bodily pain and CRP was 
significant for CG but not non-CG.  
Irwin et 
al. (1991) 
-CG: N = 48 
-Non-CG: N = 
17 
-CG: Mean age = 71.3, SD = 6.8 
F = 30, M = 18 
-Non-CG: Mean age = 71.3, SD 
= 7.3 
F = 11, M = 6 
- 
All spouses - NK activity, 
cytotoxic activity 
 
CG: No effect on NK cell activity, 
or cytotoxic activity.  
 
Irwin et 
al. (1997) 
-CG: N = 100 
-Non CG: N = 
33 
-CG: Mean age = 71, SD = 7.2 
F= 57%, M= 43% 
87% White, 4% Black, 5% 
Hispanic, 4% Asian 
-Non-CG: Mean age = 69.6, SD 
= 6.2 
F = 58%, M = 42% 
100% White 
All spouses 
 
Mean duration = 
2.1 years, SD = 
1.2 
NK cell activity 
 
  Age (over v. under 70) X CG 
interaction: non-CG who were 
younger had lowest NK activity, 
and younger CG the same as older 
non-CG. 
Jeckel et 
al. (2010) 
-CG: N = 41 
-Non-CG: N = 
33 
-CG: Mean age = 60.56, SD = 
16.56.  
F = 32, M = 9 
- 
-Non-CG: M = 60.27, SD = 14.1  
F = 26, M = 7 
- 
All spouses Mean duration = 
4.03 years, SD = 
2.89 
Mean level = 16 
hours/day, SD = 
5.73 
PBMC 
lymphocyte 
proliferation and 
steroid sensitivity  
 
CG: ↑ T-cell proliferation, ↑ 
cellular sensitivity to DEX & 
corticosterone  
Kiecolt-
Glaser et 
al. (1991) 
-CG: N = 69 
-Non-CG: N = 
69 
-CG: Mean age = 67.26, SEM = 
0.98 
F = 49, M = 20 
95% Caucasian 
-Non-CG: M = 67.75, SEM = 
0.93 
F = 49, M = 20 
93% Caucasian 
All spouses Mean duration = 
5.2 years, SEM = 
0.55 
Mean level = 8.26 
hours/day, SEM = 
0.6  
Blastogenesis 
with two 
mitogens, 
concanavalin A 
(Con A) and 
phytohemagglutin
in (PHA), as well 
as antibody titres 
to latent Epstein-
Barr virus (EBV),  
antibodies to EBV 
virus capsid 
antigen (VCA) 
IgG 
CG: greater ↑ in EBV, VCA, IgG 
antibody titres. CG: ↓ 
blastogenesis in response to ConA 
and PHA 
 
Kiecolt-
Glaser et 
al. (1995) 
-CG: N = 13 
-Non-CG: N = 
13 
-CG: Mean age = 62.3, SEM = 
2.3 
-Non-CG: Mean age = 60.4, 
SEM = 2.8 
All female 
- 
9 spouses, 4 
children 
Mean duration = 
7.8 years, SD = 
0.6 
Mean level = 6.7 
hours/day, SD = 
1.9 
Wound healing, 
IL-1beta mRNA 
production 
 
Complete wound healing took 
longer in CG. CG: ↓ IL-1beta 
mRNA in response to stimulation, 
specifically LPS (not TNF or GM-
CSF) 
 
Kiecolt-
Glaser et 
al. (1996) 
-CG: N = 32  
-Non-CG: N = 
32 
-CG: M = 73.12, SD = 8.64  
F = 18, M = 14  
-Non-CG: M = 73.3, SD = 7.94 
F = 18, M = 14  
93% Caucasian 
 
All spouses Mean duration = 
7.25 years, SD = 
3.46 
Mean level = 
8.39 hours/day, 
SD = 8.49 
Antibody 
response (4-fold 
increase) to 
vaccination, IL-
1beta & IL-6 
mononuclear 
responses to LPS 
stimulation. % of 
T-lymphocytes 
and monocytes 
> 70 years old: CG less likely to 
have antibody response to 
vaccination, despite comparable 
baseline antibodies.  CG: lower IL-
1beta, change following 
vaccination not sig, no group X 
time interaction. No effects for IL-
6. CG: lower IL-2 (no change in 
time or group X time). CG: no 
difference in percentages of 
 monocytes, CD3+, CD4+, or 
CD8+ lymphocytes 
 
Kiecolt-
Glaser et 
al. (2003) 
-CG: N = 119 
-Non-CG: N = 
106 
Mean age = 70.58, SD = 8.03. 
F = 160, M = 65 
- 
All spouses Mean duration 
= 4.91 years, 
SD = 3.63  
Mean level = 
9.72 hours/day, 
SD = 7.7  
-Bereaved CG: 
Mean = 33.71 
months, SD = 
19 since death 
of spouse 
 
 
Plasma IL-6 
 
For both continuing and 
bereaved CG, IL-6 rise ↑ across the 
6 years  
Kiecolt-
Glaser et 
al. (2011) 
-CG: N = 58 
-Non-CG: N = 
74  
 
-CG: Mean age = 70.1, SD = 9.41  
F = 41, M = 17 
-Non-CG: Mean age = 69.34, SD 
= 10.73  
F = 54, M = 20 
122 White, 10 Non-White 
Spouses and 
children 
- IL-6 
TNF-α 
Multiple childhood adversities: ↑ 
IL-6  
Abuse: ↑ IL-6 and TNF-α levels; 
for TNF-α, this relationship was 
magnified in CG  
 
Mausbac
h et al. 
(2007b) 
-CG: N = 106 Mean age = 73, SD = 8.73 
 
All spouses - Beta-adrenergic 
receptor 
sensitivity 
 
Role overload ↓ beta adrenergic 
sensitivity, and mastery but not 
depression mediated this 
Mausbac
h et al. 
(2007c) 
-CG: N = 112 
-Non-CG: N = 
53 
-CG: Mean age = 72.8, SD = 8.7 
F= 68%, M = 32% 
92% White 
-Non-CG: Mean age = 67.4, SD = 
6.9 
F = 76%, M = 24% 
All spouses Mean duration = 
3.5 years, SD = 
1.1 
Plasma t-PA 
antigen 
 
CG: ↑ t-Pa over time compared 
with non-CG 
 
92% White 
Mausbac
h et al. 
(2008) 
-CG: N = 115 Mean age = 72.6, SD = 8.8 
68.7% female 
92.2% Caucasian 
  
 
All spouses Mean duration = 
6 years, SD = 3.5 
Mean level: 
43.5% less than 7 
hrs/day, 33% 7-
12hrs/day, 12.2% 
13-18 hrs/day, 
11.3% 19+ 
hrs/day 
Beta-adrenergic 
receptors 
 
CG stress negatively associated 
and CG mastery positively 
associated with beta-adrenergic 
sensitivity 
Mills et 
al. (1997) 
-High stress 
CG: N = 10  
-Low-stress 
CG N = 17 
-Non CG: N = 
10  
-High stress CG: Mean age = 72, 
SD = 5  
F = 8, M = 2 
-Low stress CG: Mean age =75, 
SD = 7 
F = 13, M = 4 
All spouses - Beta adrenergic 
sensitivity 
 
For beta-receptor sensitivity, 
30% of the variance was accounted 
for by high life stress rating, 
increased age, being male, and 
lower NE; 17% of the variance in 
-Non-CG: Mean age = 74, SD = 
7 
F = 2, M = 8 
beta-receptor density was 
accounted for by plasma NE. 
Mills et 
al. (1999) 
-Vulnerable 
CG: N = 10 
-Non-
vulnerable: N = 
10 
-Vulnerable CG: Mean age = 
74.6, SD = 5  
F = 6, M = 4 
-Non-vulnerable CG: Mean age = 
72.4, SD = 8 
F = 6, M = 4 
- 
All spouses Level: at least 10 
(vulnerable CG) 
providing more 
than 12 hrs/day  
 
Lymphocytes 
Catecholamines 
Vulnerable CG: had 60% ↓ L-
selectin negative CD8+ T cells 
(CD8+CD62L-) but no difference 
in CD8+CD62L+ cells. 
Vulnerable CG: ↓ CD4+CD62L- T 
lymphocytes but no difference in 
CD4+CD62L+ lymphocytes. 
Acute stressor: ↑ circulating levels 
of CD8+CD62L- and 
CD8+CD62L+ lymphocytes and 
catecholamines similarly in both 
groups 
Mills et 
al. (2004) 
-Vulnerable 
CG: N = 16 
-Non-
vulnerable: N = 
53 
-Non-CG: N = 
37 
-Vulnerable CG: Mean age  = 
70.3, SD = 8.6 
F = 12, M = 4 
-Non-vulnerable: Mean age = 
74.8, SD = 8.4 
F = 31, M = 22 
-Non-CG: Mean age = 68.2, SD 
= 7.4 
F = 30, M = 7 
Most White 
All spouses Level: at least 16 
(vulnerable CG) 
providing more 
than 12 hrs/day  
 
Beta2 receptor 
sensitivity 
Vulnerable CG had lower beta2 
receptor sensitivity and density 
than non-CG (non-vulnerable did 
not differ from other groups) 
 
Mills et 
al. (2009) 
-CG: N = 81 
-Non-CG: N = 
41 
-Males (N = 34):  
CG with High CDR: Mean age = 
75.6, SD = 9.1 
CG with Low CDR: Mean age = 
77.8, SD = 3.5 
All spouses - Plasma IL-6  
plasma D-dimer   
 
Males caring for spouse with 
poorer dementia had ↑ IL-6 levels 
than non-CG or female CG for 
worse dementia  
 
Non-CG: Mean age = 70.5, SD = 
8.9 
88% Caucasian 
-Females (N = 88): 
CG with High CDR: Mean age = 
71.3, SD = 9.3 
CG with Low CDR: Mean age = 
68.5, SD = 8.2 
Non-CG: Mean age = 65.7, SD = 
6.2 
89% Caucasian 
Neri et 
al. (2007) 
-CG (BPSD): 
N = 10 
-CG (hip 
fracture/HF): N 
= 10 
-CG (BPSD): M = 60.6, SD = 7.9 
F = 8, M = 2 
-CG (HF): M = 49, SD = 8.7 
F = 10 
-CG (res): M = 56.9, SD = 4.6 
- CG (BPSD): 
Mean duration = 
36.1 months, SD = 
23.5 
Salivary IgA, 
blood IL-2 
 
No overall effect of group on IgA 
or IL-2 
-CG 
(respite/res): N = 
9 
F = 8, M = 1 
- 
Mean level = 
10.7 hrs/day, SD = 
11.2 
CG (HF): Mean 
duration = 59.4 
months, SD = 71.1 
Mean level = 3.2 
hours/days, SD = 
2.1 
CG (res): Mean 
duration = 43.3 
SD = 38.4 
Mean level = 9.6 
hrs/day, SD = 4.6 
Redwine 
et al. 
(2004) 
-CG: N = 18 
-Non-CG: N = 
9 
-CG: Mean age = 72.1, 
F = 89%  
-Non-CG: Mean age = 67.6 
F = 90%  
- 
All spouses Mean duration = 
average of 3-5 
years 
SDF-1, FMLP, 
ISO 
CG: no difference at baseline in 
chemotaxis to SDF-1, FMLP, ISO, 
but ↓ SDF-1, FMLP, ISO  
chemotaxic responses to task  
Reese et 
al. (1994) 
-Alzheimer’s 
disease (AD) 
CG: N = 25 
-Stroke (ST) 
CG: N = 25 
-Non-CG: N = 
25 
-AD CG:  M = 56.3, SD = 12.6  
F = 19, M = 6  
Caucasian = 22, African-American 
= 3 
-ST CG: M = 63.9, SD = 12.9,  
F = 15, M = 10 
Caucasian = 23, African-American 
= 2 
-Non-CG: M = 60.9, SD = 7.4 
F = 17, M = 8 
-AD CG: 9 
spouses, 14 
children, 2 other 
-ST CG: 13 
spouses, 10 
children, 2 other 
 
-AD CG: Mean 
duration = 3.7, SD 
= 1.9 years since 
diagnosis 
Mean level = 5.8 
hrs/day, SD = 4.3 
-ST CG: Mean 
duration = 3.9, SD 
= 3.4 years since 
diagnosis 
Immune 
parameters: CD3+ 
cells, CD4+ cells, 
CD8+ cells, NK 
cells, and total 
lymphocytes  
 
No group differences in immune 
data 
 
Caucasian = 22, African-American 
= 3 
Mean level = 4.4 
hrs/day, SD = 2.6 
Scanlan 
et al. 
(2001) 
-CG: N = 82 
-Non-CG: N = 
83 
 
-CG: Mean age = 69.8, SD = 7.4  
F = 53, M = 29  
81 Caucasian, 1 African-
American dyad 
-Non-CG: Mean age =69.1, SD = 
5.4  
F = 60, M = 23  
82 Caucasian, 1 African-
American/Asian 
All spouses -Male CG: Mean 
duration = 45.5 
months, SD = 20.8 
-Male CG: Mean 
duration = 52.7 
months, SD = 30.6 
 
Lymphocyte 
response to 
mitogens 
In males, depressed mood factor 
negatively related to all mitogen 
responses at T1 and PHA at T2. No 
relationships occurred in women. 
At T2 an anger expression factor 
(anger-out − anger-control) was 
negatively related to all mitogen 
responses in CG. Depressed mood 
at T1 predicted residualised 
changes in PHA at T2 in men. 
Segerstor
m et al. 
(2008) 
-CG: N = 14 
-Non-CG: N = 
30 
Mean age = 74.52, SD = 7.11 
F = 57% 
All White 
All spouses Mean duration = 
6.57 years, SD = 
2.68 
Antibody titres. 
IL-6 
 
CG: no difference in antibody titre 
to any component of vaccine.  
CG: ↑ levels of post-vaccination 
IL-6  
Thompso
n et al. 
(2004) 
-CG: N = 61 
 
-Female: Mean age = 69.7, range = 
56-87 
-Male: Mean age = 71.4, range = 
61-84 
F = 45, M = 16 
- 
All spouses -Female: Mean 
duration = 5.8 
years, range = 1-
12 years 
-Male: Mean 
duration =  5.3 
years, range = 1-
11 
Lymphocytes 
 
Male CG had ↑ % NK cells and 
lower percentage of T helper cells. 
Female CG had ↓ NK cells than 
non-CG females (from data bank).  
In men, ↑ NK cell number 
correlated with ↓ perceived stress 
and symptoms.  
Vedhara 
et al. 
(1999) 
- CG: N = 50 
-Non-CG: N = 
67  
-CG: Median = 73, interquartile 
range = 66-77  
F = 26, M = 24 
-Non-CG: Median = 68, 
interquartile range = 66-71 
F = 36, M = 31 
All Caucasian 
All spouses Mean duration = 
3.5 years, SD = 
2.7 
Influenza IgG 
antibodies 
CG: no difference in antibody 
concentrations to any vaccine 
component at baseline. Excluding 
non-responders, CG had ↓ 
response to Nanchang strain 
Vitaliano 
et al. 
(1998a) 
- CG: N = 80 
-Non-CG: N = 
85 
-CG: Mean age = 69.8, SD = 8  
F = 66%, M = 34% 
77 Caucasian, 1 African-American 
-Non-CG: M = 69.1, SD = 5.6 
F = 70%, M = 30% 
71 Caucasian, 1 African-
American/Asian dyad 
All spouses Mean duration = 
43 months, SD = 
26 
NK cell activity 
 
At time 1, CG with cancer history 
had lower NK activity (trend at 
time 2). People with cancer history 
and high hassles, low uplifts had 
less NK cell activity. 
 
Vitaliano 
et al. 
(2001) 
-CG: N = 81 
-Non-CG N = 
86  
-CG: Mean age = 69.8, SD = 7.9  
F = 64%, M = 36% 
77 Caucasian, 1 African-American 
-Non-CG: M = 69.1, SD = 5.6 
F = 71%, M = 29% 
71 Caucasian, 1 African-
American/Asian 
All spouses  NK activity CG: no difference in NK activity 
Vitaliano 
et al. 
(2007) 
-CG: N = 130 
-Non-CG: N = 
125 (at time 1) 
-CG: Mean age = 71.7, SD =8.9 
F = 62%, M = 38% 
94% Caucasian 
-Non-CG: 70.2, SD = 7.2 
F = 64%, M = 36%  
92% Caucasian 
All spouses T1: Median 
duration = 44.1 
months, Mean 
level = 7 
hours/day, SD = 
8.2  
CRP  
 
CG: no difference in CRP.  
 
Von 
Känel et 
al. (2006a) 
-CG: N = 64  
-Non-CG, N = 
36  
-CG: Mean age = 72.1, SD = 8.7  
F = 44, M = 20   
-Non-CG: Mean age =68.1, SD = 
6.6  
F = 26, M = 10 
- 
All spouses - IL-6 
 
CG: ↑ IL-6. After controlling for 
age and BMI, longer wake time 
after sleep onset and interaction 
between caregiver status and 
higher apnea–hypopnea index 
were predictors of IL-6. 
Von 
Känel et 
al.  
(2006b) 
-CG: N = 116  
-Non-CG: N = 
54 
-CG: Mean age = 72.9, SD = 8.7  
F = 79, M = 37 
-Non-CG: Mean age = 67.6, SD 
= 6.8  
All spouses - Plasma IL-6 
CRP 
 
CG: ↑ IL-6. CRP levels similar 
between groups. Age accounted 
for much of the relationship with 
IL-6. After controlling for 
F = 40, M = 14 
93% Caucasian 
covariates, interaction between 
CG status and age borderline 
significant for IL-6 (p =.090).  
CG: age correlated with IL-6.  
Von 
Känel et 
al. (2010a) 
-CG: N = 97 
-Non-CG: N = 
48 
-CG: Mean age = 72.4, SD = 8.7 
F = 71%, M = 29%  
-Non-CG: M = 67.9, SD = 7  
F = 73%, M = 27% 
- 
All spouses - CRP, IL-6, 
von Wildebrand 
factor antigen,  
CG: stronger negative correlation 
between % sleep and IL-6, % sleep 
and CRP  
 
 
Von 
Känel et 
al. (2012c) 
-CG: N = 118 
-Non-CG: N = 
51 
 
-CG: Mean age = 74.4, SD = 8.1  
F = 83, M = 35 
-Non-CG: Mean age = 74.4, SD 
= 5.9  
F = 33, M = 18 
155 Caucasian 
All spouses Mean duration =  
4.4 years, SD = 
3.4  
Mean level = 7.4 
hours/day, SD = 
5.8 
C-reactive 
protein (CRP) 
Tumour necrosis 
factor (TNF 
alpha)  
↑ duration of caregiving 
associated with ↑ CRP levels  
↑ TNF-α levels in CG  
↓ CRP, 3 months after the death 
of spouse 
Von 
Känel et 
al. (2014) 
-CG: N = 121 
 
Mean age = 74.3, SD = 8 
F = 69.4%, M = 30.6% 
All spouses Mean duration = 
4.4 years, range = 
0.5-17.1 
TNF-alpha, IL-
8, IFN-gamma, 
IL-6, CRP 
↓ leisure satisfaction and 
enjoyment from leisure activities: 
↑ TNF-alpha, IL-8, IFN-gamma, 
but not IL-6 or CRP. ↓ frequency 
of activities: higher IL-8 only  
Wu et al. 
(1999) 
-CG: N = 9 
-Non-CG: N = 
9 
CG: Mean age = 64, SD =  1.8 
years  
-Non-CG: Mean age = 68, SD = 2 
years 
All female 
 
All spouses - GH mRNA 
expression in 
PBMC, B cells 
compared to T 
cells  
GH mRNA expression in PBMC 
and B cells ↓ in CG 
 
Table 3: Summary of studies examining effects of family dementia caregiving on cardiovascular measures  
Article Sample size Participant age, gender & 
ethnicity 
Relation to care 
recipient 
Level of care 
provided 
Biomarkers 
examined 
Findings  
Aschbac
her et al. 
(2005) 
-CG: N = 60 
-Non-CG: N = 
33 
-CG: Mean age = 72.3, SD = 8.8 
F = 63%, M = 37% 
-Non-CG: Mean age = 68, SD = 
7.4 
F = 76%, M = 24% 
85 Caucasian, 3 Asian, 3 
Hispanic, 1 African-American, 1 
other  
All spouses - D-dimer CG: ↑ D-dimer, but not when 
depression and anxiety added as 
covariates 
Aschbac
her et al. 
(2006) 
-CG: N = 71 
-Non-CG: N = 
37 
-CG: Mean age = 72.58, SD = 8.48  
F = 65%, M = 35%  
93% White 
All spouses Duration: Six 
months-10 or 
more years 
 
D-dimer 
 
Clinical dementia rating: ↑ D-
dimer at baseline and in response 
to stress 
 
-Non-CG: Mean age = 67.73, SD = 
7.11  
73% female, 27% male  
89% White 
Atienza 
et al. 
(2001) 
-CG: N = 50 
 
-Female CG: N = 25, Mean age = 
70.4, SD = 8.1  
92% Caucasian 
-Male CG: N = 25, Mean age = 
72.8, SD = 9.6  
92% Caucasian  
 
-Female CG: 22 
spouses 
-Male CG: 22 
spouses 
Female: Mean = 5 
years, SD = 3.4 
Mean level = 89.5 
hours/week, SD = 
48.8 
 Males: Mean 
duration = 3.7 
years, SD = 3.0  
Mean level = 61.5 
hours/week, SD = 
41.9 
HR 
BP 
Female CG: ↑ SBP and DBP 
reactivity to stress task compared 
with male CG. No gender 
differences for ambulatory 
hemodynamic functioning 
Brummet 
et al. 
(2013) 
-CG: N = 54 
-Non-CG: N = 
23 
Mean age = 62.4, SD = 10.5  
F = 79.2%, M = 21.8%   
53.3% Caucasian, 46.7% African 
American 
Approximately 
half were spouses 
and 
approximately 
half were children 
A number of 
years 
Metabolic 
syndrome 
(Combination of 
glycosylated 
hemoglobin 
concentration 
(HbA1c%), 
triglycerides, 
waist 
circumference, 
BP) 
Cognitive decline in patient 
significantly associated with 
metabolic syndrome in CG 
 
Caciopp
o et al. 
(2000) 
-CG: N = 27 
-Non-CG: N = 
37 
Mean age = 67.17, SEM = 1.03 
83% White, 17% Black 
All female 
All spouses Mean level = at 
least 5 hours/week 
BP, HR, cardiac 
preejection period 
(PEP), respiratory 
sinus arrhythmia 
(RSA)  
CG: Higher resting HR, SBP & 
DBP, and shorter PEPs, but not 
different in baseline 
respiration/RSAI. CG showed no 
differences in cardiovascular 
physiological response 
Chattillio
n et al. 
(2013) 
-CG: N = 66 Mean age = 71.19, SD = 8.71 
F = 75.8% 
84.85% Caucasian 
58 spouses, 2 
partners, 6 
children 
 
Mean duration: 
5.22 years, SD = 
4.41 
Mean level: 8.15 
hours/day, SD = 
5.17 
Mean arterial 
pressure, SBP, 
DBP 
 
CG with ↑ engagement in pleasant 
events & ↓ perceived activity 
restriction had ↓ mean arterial BP, 
SBP & DBP 
 
Clark, et 
al. (2007) 
-New CG: N = 
80  
-Veteran CG: 
N = 120   
-Non-CG: N = 
60  
 
-New CG: Mean age = 73.9, SD = 
7.1 
62.5% female 
-Veteran CG: Mean age = 74.2, SD 
= 7.4 
65.8% female 
-Non-CG: Mean age = 71.9, SD = 
7.7 
All spouses -New CG: Mean 
duration = 5.4 
months, SD = 3.  
-Veteran CG: 
Mean = 39.7 
months, SD = 17.9 
Urinary cortisol,  
EPI 
NE  
serum DHEA-S 
(primary 
mediators),  
serum HDL 
cholesterol  
Primary mediators significantly 
associated with stress- ↑ with time 
for CG but not non-CG 
68.2% female 
 
total  cholesterol 
blood 
glycosylated 
haemoglobin 
blood pressure, 
waist-hip ratio 
(secondary 
mediators) 
Harmell 
et al. 
(2011) 
-CG: N = 100 Mean age = 73.8, SD = 8.4  All spouses Mean duration = 
4.23 +/- 3.32 years 
 
 
Mean arterial 
pressure,  
SBP 
DBP 
pulse pressure 
Coping self-efficacy related to ↓ 
resting mean arterial pressure, 
SBP, and pulse pressure, and 
marginally related to DBP  
Irwin et 
al. (2013) 
-CG: N = 32 
(10 with hospice 
CG (hospice): Mean age = 76.8, 
SD = 8.68 
 
All spouses - BP Hospice: no difference in SBP or 
DBP 
 
prior to death, 22 
without) 
 
Non-CG (no hospice): Mean age 
= 73.95, SD = 8.85 
- 
- 
Jeckel et 
al. (2010) 
-CG: N = 41 
-Non-CG: N = 
33 
-CG: Mean age = 60.56, SD = 
16.56  
F = 32, M = 9 
-Non-CG: M = 60.27, SD = 14.1  
F = 26, M = 7 
- 
All spouses Mean duration = 
4.03 years, SD = 
2.89 
Mean level = 16 
hours/day, SD = 
5.73 
BP, HR 
 
CG: ↑ DBP & heart rate  
Kim et 
al. (2007) 
-CG: N = 160 -White: Mean age = 56.62, SD = 
16.35  
 F = 69.2%, M = 30.8%  
-African-American: Mean age = 
54.71, SD = 15.27 
F = 68.4%, M = 31.6% 
- White: Mean 
duration = 4.63 
years, SD = 3.2 
Mean level = 
19.72 hours/week, 
SD = 12.99 
HR, BP 
 
Buffering effect of active coping 
on DBP in AA.  
 
95 African-American, 65 White AA: Mean 
duration = 4.07 
years, SD = 3.05 
Mean level= 
16.86 hours/week, 
SD = 10.57 
King et 
al. (2002a) 
 -CG: N = 88 Wives: Mean age = 67.9, SD = 8.7  
92.2% white 
Daughters: Mean age = 56.8, SD = 
5.4 
85% White 
All female 
 
 
52 wives, 36 
daughters 
 
Wives: Mean 
duration = 4.4 
years, SD = 3.4, 
Daughters: Mean 
duration = 3.5 
years, SD = 2.7 
Level: At least 10 
hours/week 
HR  
BP (ambulatory in 
response to acute 
stressor-
Submaximal 
treadmill exercise 
test + 
interpersonal 
interview on CG) 
No difference between wives & 
daughter on acute stressors 
Daughters had ↑ DBP and HR in 
presence of care recipient than 
wives 
Knight et 
al. (2007) 
-CG: N = 102 
-Non-CG: N = 
102 
-CG: African-American: Mean age 
= 57.15, SE = 1.95 
White: Mean age = 55.05, SE = 
2.67  
African-American: F = 45, M = 17  
White: F = 25, M = 15  
62 AA, 40 White 
-Non-CG: African-American: 
Mean age = 57.1, SE = 1.97, 
White: Mean age = 54.83, SE = 2.7 
African-American: F = 45, M = 17, 
White: F = 25, M = 15 
62 AA, 40 White 
AA: 23% spouses, 
45% children, 
31% other  
White: 30% 
spouses, 43% 
children, 25% 
other  
 
Level: At least 8 
hours/week 
BP AA CG: ↑ DBP  
 
Knight 
and 
-CG: N = 154 -White: Mean age = 62.9 years, 
SD = 12.6 
-White: 67 
spouse, 33 child, 
10 other.  
- Heart rate 
BP 
 
Race did not modulate SBP 
reactivity. For DBP, White CG 
McCallum 
(1998) 
- African-American: M = 57.7 
years, SD = 14.3 
-White: F = 78, M = 32  
- African-American: F = 36, M = 8  
110 White, 44 African-American 
-AA: 18 spouse, 
20 child, 6 other 
showed small ↑, AA males showed 
↓, AA females showed larger ↑.  
Race did not modulate HR 
Kring et 
al. (2010) 
-CG: N = 126 
-Non-CG: N = 
122 
-CG: Mean age = 63.2, SD = 13.1 
F = 91, M = 35  
-Non-CG: Mean age = 60, SD = 
14.4 
F = 91, M = 31 
All White  
96% children - Serum HDL 
cholesterol, serum 
triglyceride 
levels, waist 
circumference  
 
For rs439401, CG with TT 
genotype had worse waist 
circumference, triglycerides and 
HDL cholesterol compared to non-
CG with TT genotype. 
 
Malarke
y et al. 
(1996) 
-CG: N = 10 
-Non-CG = 16 
(10 completed 
acute stressor, 6 
did not) 
Mean age = 69 
All female 
- 
All spouses - HR, BP, MAP, 
RSA 
CG: ↑ MAP.  
Mausbac
h et al. 
(2006) 
-CG: N = 40  
  
Mean age = 73.3, SD = 8.5  
F = 26, M = 14  
38 Caucasian 
 
All spouses - Plasma D-dimer 
 
 
↑ wake after sleep onset = ↑ D-
dimer 
 
Mausbac
h et al. 
(2007a) 
-CG: N = 126 Patient mean age = 73, SD = 8.7 
F = 68%, M = 32% 
92% White, 2.4% Hispanic, 2.4% 
Asian, 0.8% African-American, 
0.8% other 
 
All spouses - Plasma D-Dimer 
 
Death/placement in institution led 
to drop in D-dimer, but only 6 
months or more after 
 
Mausbac
h et al. 
(2007c) 
-CG: N = 112 
-Non-CG: N = 
53 
-CG: Mean age = 72.8, SD = 8.7 
F= 68%, M = 32% 
92% White 
-Non-CG: Mean age = 67.4, SD = 
6.9 
F = 76%, M = 24% 
All spouses Mean duration = 
3.5 years, SD = 
1.1 
MAP 
 
CG: ↑ MAP 
 
92% White 
Mausbac
h et al. 
(2010) 
-CG: N = 55 
-Non-CG: N = 
23 
-CG: Mean age = 74.2, SD = 7.6  
F = 38, M = 17  
White = 50, Hispanic = 4, Black 
= 1 
-Non-CG: Mean age = 74.3, SD 
= 7.8  
F = 18, M = 5  
White = 19, Hispanic = 3, Asian = 
1 
All spouses  Hyperemia 
induced flow-
mediated dilation 
(FMD) 
CG for spouse with moderate to 
severe dementia: worse FMD than 
CG for spouse with mild dementia 
and non-CG 
↑ CG duration = ↓ FMD 
Mausbac
h et al. 
(2012) 
-CG: N = 116 Mean age = 74.3, SD = 8.1 
F = 68.1%, M = 31.9% 
87.1% White, 7.7% Hispanic, 
2.6% Black, 0.9% Asian, 1.7% 
Native American 
All spouses - Brachial artery 
flow-mediated 
dilation (FMD)  
 
More years CG: ↓ FMD 
 
       
Mills et 
al. (2009) 
-CG: N = 81 
-Non-CG: N = 
41 
-Males (N = 34):  
CG with High CDR: Mean age = 
75.6, SD = 9.1 
CG with Low CDR: Mean age = 
77.8, SD = 3.5 
Non-CG: Mean age = 70.5, SD = 
8.9 
88% Caucasian 
-Females (N = 88): 
CG with High CDR: Mean age = 
71.3, SD = 9.3 
CG with Low CDR: Mean age = 
68.5, SD = 8.2 
Non-CG: Mean age = 65.7, SD = 
6.2 
89% Caucasian 
All spouses - BP, plasma D-
dimer,   
Males caring for spouse with 
poorer dementia had ↑ D-dimer 
than female CG for worse 
dementia and compared to non-CG 
 
Redwine 
et al. 
(2004) 
-CG: N = 18 
-Non-CG: N = 
9 
-CG: Mean age = 72.1, 
F = 89%  
-Non-CG: Mean age = 67.6 
F = 90%  
- 
All spouses Mean duration = 
average of 3-5 
years 
BP, HR 
 
No difference in baseline BP or 
HR 
Roepke 
et al. 
(2011a) 
-CG: N = 111 
-Non-CG: N = 
51 
-CG: Mean age = 73.6, SD = 8.2 
F = 76, M = 35 
102 White, 6 other 
 -Non-CG: Mean age = 74.7, SD = 
6.4 
F = 35, M = 16 
43 White, 7 other 
All spouses Mean duration: 
4.2 years, SD = 
3.5 
BP, carotid artery 
imaging 
 
CG: ↑ carotid plaques, and poor 
EPI recovery = ↑ plaque 
prevalence  
Roepke 
et al. 
(2011b) 
-CG: N = 87  
-Non CG: N = 
43  
-CG: Mean age = 74.3, SD = 7.8  
F = 62, M = 25  
83 Caucasian, 2 Non-Caucasian 
All spouses Mean duration: 
4.3 years, SD = 
3.4 
Allostatic load 
(composite of BP, 
BMI , NE, EPI, 
cholesterol) 
CG: ↑ allostatic load. Mastery, but 
not depression or overload, 
moderated the relationship 
-Non-CG: Mean age = 74.9, SD 
= 6.8  
F = 26, M = 17  
38 Caucasian, 4 Non-Caucasian 
between CG status and allostatic 
load 
Roepke 
et al. 
(2012) 
-CG: N = 110 Mean age = 73.7, SD = 8.2 
F = 76, M = 34 
102 Caucasian 
All spouses Mean duration = 
4.2 years, SD = 
3.5  
BP, carotid artery 
imaging (IMT) 
 
CG duration not a predictor of 
IMT, but significant predictor of 
internal/bifurcation IMT 
Sakurai 
et al. 
(2015) 
-CG: N = 20 
-Non-CG: N = 
20  
CG: Median age = 60 (25th-75th 
percentile: 56-65.8) 
F = 16, M = 4 
Non-CG: Median age = 64.5 (25th-
75th percentile: 59.3-69).  
F = 16, M = 4 
- 
7 spouses, 10 
children, 3 child-
in-law 
Median duration 
= 3.9 years (25th-
75th percentile = 
2.4-5.2) 
R-R heart wave 
 
CG: ↑ LF/HF ratio during first 
half. No difference in HF 
amplitude. Greater change in HF 
ratio between first and second half 
of sleep in CG.  
Sarabia-
Cobo et al. 
(2015) 
-Family CG: 
32 
-Pro CG: 42 
-Family CG: Mean age = 59.2 
F = 86%, M = 14% 
-Pro CG: Mean age = 42.7 
F = 83%, M = 17% 
- 
- Family CG: Mean 
duration = 9.8 
years  
Pro CG: Mean 
duration = 11.7 
years 
 
Heart coherence 
 
CG: ↑ burden levels = ↓ heart 
coherence. Burnout associated 
with low coherence for 
professional CG as well. After 3 
months' training, no difference 
found in heart coherence for 
family v. professional CG. Heart 
coherence training = ↓ burnout and 
burden and ↑ heart coherence 
Schwartz 
et al. 
(2013) 
-CG: N = 126 Mean age = 74.16, SD = 7.98 
F = 89, M = 37 
115 Caucasian, 10 non-Caucasian 
 
All spouses Mean duration = 
4.33 years, SD = 
3.38 
 
Dyslipidemia, 
hypertension 
 
Night time sleep duration, night 
time sleep efficiency and daytime 
naps not significantly associated 
with dyslipidemia, or hypertension 
 
Shaw et 
al. (1999) 
-CG: N = 144  
-Non-CG: N = 
47 
-CG: M = 70.5, SD = 7  
F = 93, M = 51 
-Non-CG: M = 70.2, SD = 6.4 
F = 24, M = 23 
- 
All spouses Mean duration = 
1.9 years, SD = 
1.2 
Level: N = 11: 
no care, N = 44: 1-
6 hours/day, N = 
24: 7-12 
hours/day, N = 31: 
13-18 hours/day, 
N = 29: 19-24 
hours/day 
BP, HR 
 
CG: no difference in baseline BP, 
CG: more likely to develop BP 
readings consistent with 
borderline hypertension at follow-
up. ADL and problem behaviours 
not significant predictors. 
 
Shaw et 
al. (2003) 
-CG: N = 111 Mean age = 71.6, SD = 6.5 
F = 78, M = 33 
102 White (non-Hispanic), 3 
African American, 3 Hispanic, 3 
Asian, Pacific Islander 
All spouses Mean years since 
AD diagnosis = 
4.5 years, SD = 
3.3  
BP 
 
More problem behaviours and less 
emotional expression = ↑ DBP. 
Longitudinal ↑ in DBP predicted 
by ADL assistance, not emotional 
Mean years since 
first symptoms = 
7, SD = 4.8 
Level: N = 9: no 
care, N = 28: 1-6 
hours/day, N = 26: 
7-12 hours/day, N 
= 26: 13-18 
hours/day, N = 22: 
19-24 hours/day 
expression. State hostility 
unrelated to BP.  
 
Thompso
n et al. 
(2004) 
-CG: N = 61 
 
-Female: Mean age = 69.7 range = 
56-87 
-Male: Mean age = 71.4, range = 
61-84 
F = 45, M = 16 
- 
All spouses -Female: Mean 
duration = 5.8 
years, range = 1-
12 years 
-Male: Mean 
duration =  5.3 
Skin conductance 
HR 
Females had ↑ HR, ↓ skin 
conductance at baseline and during 
post-stress relax phase 
years, range = 1-
11 
Uchino 
et al. 
(1992) 
-CG: N = 36 
-Non-CG: N = 
34 
Median age = 63.5, range = 30-
84 
-CG: F = 23, M = 13 
-Non-CG: F = 28, M = 6 
- 
- Mean duration =  
101.97 months 
Level: At least 5 
hours/week 
HR  
BP 
 
CG: comparable age-related 
increases in SBP and HR. For HR 
reactivity, social support 
attenuation age-related ↑, but only 
in CG 
Uchino 
et al. 
(1994) 
-CG: N = 31 Mean age = 61.87 years 
F = 18, M = 13 
- 
 
20 spouse, 10 
children, 1 in-law 
 
Mean duration = 
7.35 years 
Level: At least 5 
hours per week 
 
HR  
BP 
 
Closer affective bonds: ↓ resting 
DBP. 
Higher preillness cohesiveness 
associated with ↑ DBP and SBP 
 
Vitaliano 
et al. 
(1998b) 
-CG: N = 71  
-Non-CG: N = 
70 
-CG: Mean age = 69.8, SD = 8  
F = 66%, M = 34% 
70 White, 1 AA 
All spouses Mean duration = 
43 months, SD = 
27 
BP 
Lipids 
 
CG: ↑ Metabolic syndrome levels, 
but only those with CHD 
-Non-CG: Mean age = 69.1, SD = 
5.6 
F = 70%, M = 30% 
69 White, 1 African-American 
/Asian-American dyad 
Vitaliano 
et al. 
(2001) 
-CG: N = 81 
-Non-CG N = 
86  
-CG: M = 69.8, SD = 7.9  
F = 64%, M = 36% 
77 Caucasian, 1 African-American 
-Non-CG: M = 69.1, SD = 5.6 
F = 71%, M = 29% 
71 Caucasian, 1 African-
American/Asian 
All spouses  Cardiovascular 
composite 
CG: no difference in 
cardiovascular composite  
Vitaliano 
et al. 
(2002) 
-CG: N = 72 
-Non-CG: N = 
80 
-CG: Mean age = 71.5, SD = 4.8 
F = 48 (20 using HRT, 28 without 
HRT), M = 24  
71 Caucasian, 1 African-American  
All spouses Male: Mean 
duration = 36.3 
months, SD = 21.9  
Measures of 
metabolic 
syndrome (BP, 
plasma lipids, 
In males, CG had higher obesity 
and lipids. CG had higher 
prevalence of CHD 
-Non-CG: Mean age = 69, SD = 
5.4 
F = 57 (21 using HRT, 36 without 
HRT), M = 23  
79 Caucasian, 1 African-
American/Asian dyad 
Female w/o 
HRT: Mean 
duration = 41.9 
months, SD = 24.9 
Female using 
HRT: Mean 
duration = 55.8, 
SD = 35.8 
insulin, BMI/with 
obesity) 
 
Von 
Känel et 
al. (2001) 
-CG: N = 53 Mean age = 73, range = 59-82 
F = 35, M = 18 
- 
All spouses - D-dimer D-dimer ↑ more in response to 
acute stress in those with CV 
disease 
 
Von 
Känel et 
al. (2003)  
-CG: N = 54 Mean age = 73, SD = 6 All spouses - D-dimer Negative life events associated 
with greater D-dimer 
 
Von 
Känel et 
al. (2005) 
-CG: N = 48 
-Non-CG: N = 
20  
-CG: Mean age = 72, SD = 9  
F = 30, M = 18 
- 
-Non-CG: Mean age = 68, SD = 7 
F = 16, M = 4  
- 
All spouses - D-dimer 
 
CG: higher D-dimer  
 
Von 
Känel et 
al. (2006a) 
-CG: N = 64  
-Non-CG, N = 
36  
-CG: Mean age = 72.1, SD = 8.7  
F = 44, M = 20   
-Non-CG: Mean age = 68.1, SD 
= 6.6  
F = 26, M = 10 
All spouses - D-dimer CG: ↑ D-dimer. Controlling for 
age, CG status independently 
predicted D-dimer levels. 
Controlling for age and caregiver 
status, lower sleep efficiency and 
the interaction between caregiver 
status and more Stage 2 sleep 
independently predicted plasma 
D-dimer levels. 
Von 
Känel et 
al.  
(2006b) 
-CG: N = 116  
-Non-CG: N = 
54 
-CG: Mean age = 72.9, SD = 8.7  
F = 79, M = 37 
-Non-CG: Mean age = 67.6, SD 
= 6.8  
F = 40, M = 14 
All spouses  D-dimer levels CG: ↑ D-dimer. Relationship 
between CG status and D-dimer 
affected by role overload.  
After controlling for covariates, 
interaction between CG status and 
age significant for D-dimer.  
CG: age correlated with D-dimer.  
Von 
Känel et 
al. (2010a) 
-CG: N = 97 
-Non-CG: N = 
48 
-CG: Mean age = 72.4, SD = 8.7 
F = 71%, M = 29%  
- 
-Non-CG: M= 67.9, SD = 7  
F = 73%, M = 27% 
- 
All spouses - D-dimer CG: positive correlation between 
duration of awakenings and D-
dimer (not significant when 
controlling for covariates) 
 
 
Von 
Känel et 
al. (2010b) 
-CG: N = 108 Mean age = 74, SD = 8 
F = 70%, M = 30% 
- 
All spouses Duration: N = 33: 
less than 2 years, 
Procoagulent 
index (sum of 
standardized z-
↑ problem behaviours and CG 
negative reaction to behaviours = ↑ 
procoagulent index 
N = 41: 2-5 years, 
N = 34: 5 years+ 
 
scores of VWF, 
PAI-1, and D-
dimer dividing the 
sum by 3) 
Wilcox 
et al. 
(2005) 
-CG: N = 28  -Caucasian CG: N = 16, Mean 
age =65.69, SD = 10.5 
- African-American CG: N = 12, 
Mean age = 62, SD = 10.2  
All female 
 
-Caucasian CG: 
8 spouse, 8 
children 
-AA CG: 3 
spouse, 7 children, 
2 siblings 
-Caucasian CG: 
Mean duration = 
47.56 months, SD 
= 43.89 
Mean level = 
73.75 hours/week, 
SD = 56.65 
-AA CG: Mean 
duration = 60 
months, SD = 
40.97,  
BP 
Heart rate 
 
Race x Task interaction for SBP 
and HR but not DBP reactivity. 
AA women showed greater 
reactivity than Caucasian women.  
Mena level = 
96.08 hours/week, 
SD = 42.54 
Zhang et 
al. (2006) 
-CG: N = 75 
-Non-CG: N = 
82 
-CG: Mean age = 69.8, SD = 8  
F = 66%, M = 34% 
-Non-CG: Mean age = 69.1, SD = 
5.6 
F = 70%, M = 30% 
All White 
All spouses - Risk composite of 
BP, lipids, BMI, 
insulin, glucose 
 
CG ↑ risk in males, Cg status did 
not ↑ risk in females 
Table 4: Summary of studies examining effects of family dementia caregiving on epinephrine/norepinephrine 
Article Sample size Participant age, gender & 
ethnicity 
Relation to care 
recipient 
Level of care 
provided 
Biomarkers 
examined 
Findings  
Adler et 
al. (2002) 
-CG: N = 67 Mean age = 73 (Range: 56-82) 
F = 45, M = 22 
88% Caucasian 
- - EPI 
NE 
Speech stressor ↑ plasma EPI and 
NE. 
Aschbac
her et al. 
(2008) 
-CG: N = 39 
-Non-CG: N = 
31 
-CG: Mean age = 68.7, SD = 7.99  
F = 25, M = 14   
-Non-CG: Mean age = 71.87, SD 
= 7.07  
F = 22, M = 9 
65 Caucasian 
 
All spouses Mean duration = 
9 years 
Plasma NE 
 
CG: ↑ symptoms of depression 
and anxiety associated with 
delayed NE recovery.  
Caciopp
o et al. 
(2000) 
-CG: N = 27 
-Non-CG: N = 
37 
Mean age = 67.17, SEM = 1.03 
83% White, 17% Black 
All female 
All spouses Mean level = at 
least 5 hours/week 
Plasma EPI  
NE 
CG: Not different in baseline 
plasma EPI/NE or EPI/NE in 
response to stress 
Chattillio
n et al. 
(2012) 
- CG: N = 107  Mean age = 73.95, SD = 8.12 
years 
F = 73, M = 34 
Caucasian = 101, Other = 5 
 
All spouses Mean level = 7.6 
hours/day, SD = 
5.91 
EPI 
NE 
CG with ↓ leisure satisfaction: 
time caregiving positively 
associated with plasma NE and 
EPI.  
 
Clark, et 
al. (2007) 
-New CG: N = 
80  
-Veteran CG: 
N = 120   
-Non-CG: N = 
60.  
 
-New CG: Mean age = 73.9, SD = 
7.1 
62.5% female 
-Veteran CG: Mean age = 74.2, SD 
= 7.4 
65.8% female 
-Non-CG: Mean age = 71.9, SD = 
7.7 
All spouses -New CG: Mean 
duration = 5.4 
months, SD = 3.  
-Veteran CG: 
Mean = 39.7 
months, SD = 17.9 
Urinary cortisol,  
EPI 
NE  
serum DHEA-S 
(primary 
mediators),  
 
Primary mediators significantly 
associated with stress-↑ with time 
for CG but not non-CG 
68.2% female 
Ho et al. 
(2014) 
-CG: N = 84 -CG: Mean age = 70.7, SD = 8.46  
F = 75%, M = 25%  
86.9% Caucasian, 13.1% other 
All spouses Mean duration = 
4.9 years, SD = 
4.1 years 
Resting EPI  
NE 
 
Mean duration of CG a significant 
predictor of EPI, not NE. Activity 
restriction did not predict EPI, 
with a trend for NE. Years 
predicted EPI but not NE when CG  
activity restriction ↑ 
Irwin et 
al. (1991) 
-CG: N = 48 
-Non-CG: N = 
17 
-CG: Mean age = 71.3, SD = 6.8 
F = 30, M = 18 
-Non-CG: Mean age = 71.3, SD 
= 7.3 
F = 11, M = 6 
- 
 
All spouses - EPI  
NE 
 
CG: No difference in EPI or NE. 
CG did not differ for dynamic 
activity of NE/EPI following 
orthostatic challenge 
 
Irwin et 
al. (1997) 
-CG: N = 100 
-Non CG: N = 
33 
-CG: Mean age = 71, SD = 7.2 
F= 57%, M= 43% 
87% White, 4% Black, 5% 
Hispanic, 4% Asian 
-Non-CG: Mean age = 69.6, SD 
= 6.2 
F = 58%, M = 42% 
100% White 
All spouses 
 
Mean duration = 
2.1 years, SD = 
1.2 
EPI  
NE  
 
CG: EPI, NE. Dementia severity 
did not predict physiological 
variables.  
Malarke
y et al. 
(1996) 
-CG: N = 10 
-Non-CG = 16 
(10 completed 
acute stressor, 6 
did not) 
Mean age = 69 
All female 
- 
All spouses - EPI  
NE  
CG: no difference in EPI/NE. CG 
did not differ in stress response  
Mausbac
h et al. 
(2005) 
-CG: N = 55 
 
-CG: Mean age = 72.64, SD = 
8.46  
F = 39, M = 16  
All spouses   - NE Depressive symptoms predicted 
post-stressor NE change after 
controlling for age, CG distress, 
51 Caucasian, 2 Asian, 1 Hispanic, 
1 Other 
 
hypertension, and care recipient 
cognitive function. Depressive 
symptoms associated with ↑ 
plasma NE response to 
psychological stress task 
Mausbac
h et al. 
(2006) 
-CG: N = 40  
  
Mean age = 73.3, SD = 8.5  
F = 26, M = 14  
38 Caucasian 
 
All spouses - EPI 
NE 
↑ wake after sleep onset = ↑ NE  
No association between sleep 
variables and EPI 
Mills et 
al. (1997) 
-High stress 
CG: N = 10  
-Low-stress 
CG N = 17 
-Non CG: N = 
10  
-High stress CG: Mean age = 72, 
SD = 5  
F = 8, M = 2 
-Low stress CG: Mean age = 75, 
SD = 7 
F = 13, M = 4 
All spouses - Plasma NE 
 
CG with high life stress: ↑ plasma 
NE  
-Non-CG: Mean age = 74, SD = 
7 
F = 2, M = 8 
- 
Mills et 
al. (1999) 
-Vulnerable 
CG: N = 10 
-Non-
vulnerable: N = 
10 
-Vulnerable CG: Mean age = 
74.6, SD = 5  
F = 6, M = 4 
-Non-vulnerable CG: Mean age = 
72.4, SD = 8 
F = 6, M = 4 
- 
All spouses Level: at least 10 
(vulnerable CG) 
providing more 
than 12 hrs/day  
 
EPI Resting plasma EPI levels ↑ 
vulnerable CG than non-
vulnerable. Acute stressor: ↑ 
circulating levels of EPI similarly 
in both groups 
Redwine 
et al. 
(2004) 
-CG: N = 18 
-Non-CG: N = 
9 
-CG: Mean age = 72.1 
F = 89%  
-Non-CG: Mean age = 67.6 
F = 90%  
- 
All spouses Mean duration = 
average of 3-5 
years 
EPI  
NE 
 
CG: no difference in baseline EPI 
or NE 
Roepke 
et al. 
(2008) 
-CG: N = 68 Mean age = 72.8, SD = 8.8 
F = 45, M = 23 
63 Caucasian, 5 non-Caucasian 
All spouses - Plasma NE 
 
ADL: Associated with heightened 
NE reactivity to speech stressor. 
Mastery ↓ NE recovery 
Roepke 
et al. 
(2011a) 
-CG: N = 111 
-Non-CG: N = 
51 
-CG: Mean age = 73.6, SD = 8.2 
F = 76, M = 35 
102 White, 6 other 
 -Non-CG: Mean age = 74.7, SD = 
6.4 
F = 35, M = 16 
43 White, 7 other 
All spouses Mean duration: 
4.3 years, SD = 
3.5 
NE, EPI, carotid 
artery imaging 
 
CG: Poor EPI recovery = ↑ 
plaque prevalence  
Roepke 
et al. 
(2011b) 
-CG: N = 87  
-Non CG: N = 
43  
-CG: Mean age = 74.3, SD = 7.8  
F = 62, M = 25  
83 Caucasian, 2 Non-Caucasian 
-Non-CG: Mean age = 74.9, SD 
= 6.8  
F = 26, M = 17  
All spouses Mean duration: 
4.3 years, SD = 
3.4 
Allostatic load 
(composite of BP, 
BMI , NE, EPI, 
cholesterol) 
CG: ↑ allostatic load. Mastery, 
but not depression or overload, 
moderated the relationship 
between CG status and allostatic 
load 
38 Caucasian, 4 Non-Caucasian 
 
 
 
 
Table 5: Summary of studies examining effects of family dementia caregiving on neurocognition and neurotrophins 
Article Sample size Participant age, gender & 
ethnicity 
Relation to care 
recipient 
Level of care 
provided 
Biomarkers 
examined 
Findings  
Burns, et 
al. (2002) 
-CG: N = 33 
-Non-CG: N = 
33 
-CG: Mean age = 55.6, SD = 13.5 
F = 82%, M = 18% 
73% Caucasian, 27 African-
American   
-Non-CG: Mean age = 55.4, SD 
= 14.1  
F = 82%, M = 18%  
73% Caucasian, 27 African-
American 
First degree 
relative, spouse or 
in-law 
- Concentration and 
problem solving 
(Proofreading 
task, Embedded 
Figure Test) 
 
CG ↓ time on the embedded 
figures test  
CG: Trend for missing more 
errors on proofreading test.  
Caswell 
et al. 
(2003) 
-CG: N = 44 
-Non-CG: N = 
66 
-CG: Mean age = 74.27, SD = 
7.91 
F = 52.3%, M = 47.7%  
All spouses - Information 
processing speed, 
concentration and 
CG: ↓ DST overall performance. 
Explained by CG status as well as 
age and education, but no longer 
-Non-CG: Mean age = 70.85, SD 
= 6.32 
F = 68.2%, M = 31.8%. 
All Caucasian 
attention (Digit 
symbols test; 
DST) 
 
significant when distress was 
added to equation  
Correa et 
al. (2015) 
-CG: N = 17  
-Non-CG: N = 
18  
-CG: Mean age: 64.83, SEM = 
3.64  
F = 13, M = 5 
-Non-CG: Mean age = 58.29, 
SEM = 3.16  
F = 14, M = 3 
- 
- Duration: at least 
one year  
Level: at least 8 
hours per day  
Logical/episodic 
Memory (Story 
recall), Working 
memory (Digit 
Span), Executive 
function (Trail 
Making) 
CG: ↓ cognitive performance 
(Digit Span and Trail Making B 
post-covariate adjustment) 
 
De Vugt 
et al. 
(2006) 
-CG: N = 54 
-Non-CG: N = 
108 
-CG: Mean age = 68.4, SD = 8.5  
F = 59.3%, M = 40.7%  
-Non-CG: Mean age = 68.3, SD 
8.4 
F = 59.3%, M = 40.7%  
All spouses Median duration 
= 24 months, 
range = 3-120 
months 
Verbal memory 
(Auditory verbal 
learning test), info 
processing speed 
(letter digit coding 
CG: ↓ performance in delayed 
recall and speed of information 
processing, trend for ↓ 
performance in cognitive 
flexibility. CG did not differ in IQ  
- Mean level =  
153.6 hours/week, 
SD = 14.1 
test), Stroop 
(cognitive 
flexibility), IQ 
(Groninger 
Intelligence Test-
short) 
 
Oken et 
al. (2011) 
- CG: N = 31 
-Non-CG: N 
=25 
-CG: Mean age = 64.5, SD = 9.3  
F = 25, M = 6  
-Non-CG: Mean age = 66.5, SD 
= 7.6  
F = 22, M = 3  
23 spouses  Level: minimum 
10 hours/week 
Attention 
(Attention 
network test), 
cognitive 
flexibility 
(Stroop), verbal 
memory (CERAD 
word list) 
CG: ↓ performance Attention 
network test and Stroop, no 
difference in verbal memory  
Palma et 
al. (2011) 
-CG: N = 14   
-Non CG: N = 
24 
-CG: Age range = 66-74 
F = 7, M = 7 
-Non-CG: Age range = 61-82 
F = 20, M = 4 
- Duration: at least 
1 year 
Level: at least 6 
hours/day 
Logical/episodic 
Memory (Story 
recall) 
 
CG: ↓ recall, memory ↑ for 
emotionally valenced story only 
for non-CG.  
 
Vitaliano 
et al. 
(2009) 
-CG: N = 130 
-Non-CG: N = 
13 
 
-CG: Mean age = 71.7, SD = 8.9  
F = 62%, M = 38% 
94% White 
-Non-CG: Mean age = 70.2, SD = 
7.2 
F = 64%, M = 32% 
92% White 
All spouses Median duration 
= 44.1 months 
Mean level = 7 
hours/day, SD = 
8.2 
Information 
processing speed, 
concentration and 
attention (DST) 
 
CG: ↓ DST scores at T1, 1-tear 
and 2-year follow-up, and declined 
4.5 times faster than non-CG 
Vitaliano 
et al. 
(2007) 
-CG: N = 130 
-Non-CG: N = 
125 (at time 1) 
-CG: Mean age = 71.7, SD = 8.9 
F = 62%, M = 38% 
94% Caucasian 
-Non-CG: 70.2, SD = 7.2 
All spouses Mean level = 7 
hours/day, SD = 
8.2  (At T1) 
Information 
processing speed, 
concentration and 
attention (DST) 
CG: ↓ DST at T1 and 2-year 
follow-up  
 
F = 64%, M = 36%  
92% Caucasian 
 
Table 6: Summary of studies examining effects of family dementia caregiving on other markers of stress  
Article Sample size Participant age, gender & 
ethnicity 
Relation to care 
recipient 
Level of care 
provided 
Biomarkers 
examined 
Findings  
Aschbac
her et al. 
(2007)  
-CG: N = 51 
-Non-CG: N = 
27 
Mean age = 77, SD = 6.8 
All female 
95% Caucasian 
All spouses Mean duration = 
7.75 years, SD = 
2.49 
BMI CG: No sig difference for BMI 
Bauer et 
al. (2000) 
-CG: N = 49 Mean age = 72, SD = 7.7  
F = 24, M = 25  
All Caucasian  
All spouses - BMI 
 
CG: No sig difference for BMI 
Brummet 
et al. 
(2005) 
-CG: N = 147 
-Non-CG: N = 
147 
-CG: Mean age = 60.6, SD = 13.1 
F = 110, M = 37 
38 African-American 
 -Non-CG: Mean age = 55.7, SD = 
14.3 
F = 111, M = 36 
96% children Duration: 
Majority active 
for 3 months or 
longer 
 
Plasma glucose  
 
CG: ↑ glucose for those with worse 
neighbourhood characteristics  
42 African-American 
Da Roza 
Davis et al. 
(2001) 
-CG: N = 30 
-Non-CG: N = 
28 
-CG: Mean age = 68.8, range = 
30-75 years  
F = 18, M = 12 
-Non-CG: Mean age = 68.1, 
range = 35-84 years  
F = 17, M = 11 
-  
- - Plasma 
tryptophan 
 
CG: ↓ total tryptophan, no 
difference in free tryptophan 
Damjano
vic et al. 
(2007) 
-CG: N = 41 
-Non-CG: N = 
41 
Mean age = 65, SD = 1 
-CG: F = 30, M = 11 
-Non-CG: F = 30, M = 11 
 - 
26 spouses, 15 
children 
Mean duration = 
5.2 years, SD = 
0.5 
PBMC telomere 
length, telomerase 
activity 
CG: ↓ telomere lengths in PBMC. 
CG: ↑ basal telomerase activity in 
PBMC and T cells  
Epel et 
al. (2010) 
-CG: N = 22 
-Non-CG: N = 
22 
Mean age = 62, range = 51-75  
All female  
 84% Caucasian, 5% African 
American, and 11% Asian 
All spouses/ 
partners 
Level: at least 4 
hours/day 
PBMC telomerase 
activity 
 
CG: ↓ telomerase activity at 
baseline and ↓ telomerase activity 
across timepoints. Similar ↑ in 
telomerase activity in response to 
acute stress  
Fonareva 
et al. 
(2011) 
-CG: N = 20 
-Non-CG: N = 
20 
-CG: Mean age = 64.5, SD = 7.13  
F = 18, M = 2 
-Non-CG: Mean age = 66.95, SD = 
7.89 
F = 18, M = 2 
97.5% White 
70% spouses, 
30% children 
- Sleep 
polysomnography  
 
CG: ↑ sleep time in stage N1, ↓ in 
stage R, similar time in stages N2 
and N3   
Kiecolt-
Glaser et 
al. (2011) 
-CG: N = 58 
-Non-CG: N = 
74  
 
-CG: Mean age = 70.1, SD = 9.41  
F = 41, M = 17 
-Non-CG: Mean age = 69.34, SD 
= 10.73  
F = 54, M = 20 
122 White, 10 Non-White 
Spouses and 
children 
- Telomere length  
 
Multiple childhood adversities: ↓ 
telomere length  
Kring et 
al. (2010) 
-CG: N = 126 -CG: Mean age = 63.2, SD = 13.1 
F = 91, M = 35  
96% children - Plasma glucose, 
serum insulin  
No significant difference in 
glucose/insulin 
-Non-CG: N = 
122 
-Non-CG: Mean age = 60, SD = 
14.4 
F = 91, M = 31 
All White  
 
Mills et 
al. (2009) 
-CG: N = 81 
-Non-CG: N = 
41 
-Males (N = 34):  
CG with High CDR: Mean age = 
75.6, SD = 9.1 
CG with Low CDR: Mean age = 
77.8, SD = 3.5 
Non-CG: Mean age = 70.5, SD = 
8.9 
88% Caucasian 
-Females (N = 88): 
CG with High CDR: Mean age = 
71.3, SD = 9.3 
All spouses - Sleep 
polysomnography 
 
Males caring for spouse with more 
severe dementia had more time 
awake after sleep onset (WASO) 
and trend for poorer sleep 
efficiency than female CG for 
worse dementia  
CG with Low CDR: Mean age = 
68.5, SD = 8.2 
Non-CG: Mean age = 65.7, SD = 
6.2 
89% Caucasian 
Roepke 
et al. 
(2011a) 
-CG: N = 111 
-Non-CG: N = 
51 
-CG: Mean age = 73.6, SD = 8.2. 
F = 76, M = 35 
102 White, 6 other 
 -Non-CG: Mean age = 74.7, SD = 
6.4 
F = 35, M = 16 
43 White, 7 other 
All spouses Mean duration: 
4.2 years, SD = 
3.5 
Sleep actigraphy 
 
CG: No difference in sleep 
efficiency 
Sakurai 
et al. 
(2015) 
-CG: N = 20 
-Non-CG: N = 
20  
-CG: Median age = 60 (25th-
75th percentile: 56-65.8) 
F = 16, M = 4 
7 spouses, 10 
children, 3 child-
in-law 
Median duration 
= 3.9 years (25th-
75th percentile = 
2.4-5.2) 
Sleep actigraphy  
 
CG: No difference in sleep 
latency, time, efficiency, or wake 
after sleep onset 
-Non-CG: Median age = 64.5 
(25th-75th percentile: 59.3-69).  
F = 16, M = 4 
- 
Thompso
n et al. 
(2004) 
-CG: N = 61 
 
-Female: Mean age = 69.7, range = 
56-87 
-Male: Mean age = 71.4, range = 
61-84 
F = 45, M = 16 
- 
All spouses -Female: Mean 
duration = 5.8 
years, range = 1-
12 years 
-Male: Mean 
duration =  5.3 
years, range = 1-
11 
Skin temperature  Women had ↓ skin temp at 
baseline and during post-stress 
relax phase 
Tomiya
ma et al. 
(2012) 
-CG: N = 14 
-Non-CG = 9 
Mean age = 62, SD = 6.46 
All female 
82% White, 11% Asian, 5% Black, 
2% Latina 
All partners - PBMC telomere 
length  
BMI 
CG: no difference in telomere 
length or BMI 
 
Vitaliano 
et al. 
(1996a)  
-CG: N = 81 
-Non-CG: N = 
86 
-CG: Mean age = 69.8, SD = 8 
 F = 64%, M = 36%. 
 80 White, 1 African-American 
-Non-CG: Mean age = 69.1, SD = 
5.6 
F = 70%, M = 30% 
85 White, 1 African-
American/Asian dyad 
All spouses -Male CG: Mean 
duration = 40.1 
months, SD = 24.8  
-Female CG: 
Mean duration = 
47.2 months, SD = 
29.5 
 
BMI 
 
Male CG: ↑ BMI at T1 and T2. 
Female CG: No difference in BMI, 
but gained more weight between 
T1 and T2  
Vitaliano 
et al. 
(1996b) 
-CG: N = 78  
-Non-CG: N = 
72 
-CG: Mean age = 69.8, SD = 7.4  
F = 47, M = 26  
77 Caucasian, 1 African-
American. 
-Non-CG: Mean age =69.1, SD = 
5.4  
F = 50, M = 22.  
All spouses -Male CG: Mean 
duration = 45.5 
months, SD = 20.8  
-Female CG: 
Mean duration = 
69.1 months, SD = 
5.4 
 
Insulin  
Glucose 
CG: ↑ hostility = ↑ glucose 
 
71 Caucasian, 1 African-
American/Asian 
Vitaliano 
et al. 
(1996c) 
-CG: N = 78  
-Non-CG: N = 
72 
-CG: Mean age = 69.8, SD = 7.4  
F = 65%, M = 35%  
77 Caucasian, 1 African-
American. 
-Non-CG: Mean age =69.1, SD = 
5.4  
F = 69%, M = 31%  
71 Caucasian, 1 African-
American/Asian dyad 
All spouses -Male CG: Mean 
duration = 45.5 
months, SD = 20.8 
-Female CG: 
Mean duration = 
52.7 months, SD = 
30.6 
 
Insulin 
Glucose 
Differences in psychological 
distress mediated higher insulin in 
CG at T2. CG: no difference in 
glucose, but psychological distress 
= ↑ glucose at T2 (controlling for 
T1) 
Vitaliano 
et al. 
(2005) 
-CG: N =110 
-Non-CG: N = 
105  
 
-CG: Mean age = 72.2, SD = 9.3 
F = 60%, M = 40% 
93% Caucasian, 7% non-
Caucasian  
All spouses - Glucose, insulin, 
BMI 
 
CG: ↑ insulin, glucose, obesity  
-Non-CG: Mean age = 71, SD = 
6.9 
F = 62%, M = 38% 
94% Caucasian, 6% non-
Caucasian 
Von 
Känel et 
al. (2010a) 
-CG: N = 97 
-Non-CG: N = 
48 
-CG: Mean age = 72.4, SD = 8.7 
F = 71%, M = 29%  
-Non-CG: M= 67.9, SD = 7  
F = 73%, M = 27% 
- 
All spouses - Sleep actigraphy CG: ↓ % sleep, wake after sleep 
onset, ↑ duration of awakenings  
 
 
Von 
Känel et 
al. (2012a)  
-CG: N = 109  
-Non-CG: N = 
48  
 
-CG: Mean age = 74.1, SD = 8.1  
F = 69.7%, M = 30.3% 
-Non-CG: Mean age = 74.7, SD 
= 6 
F = 62.5%, M = 37.5% 
92% Caucasian, 8% other 
All spouses Mean duration = 
4.5 years, SD = 
3.5 years 
Sleep actigraphy 
 
Spousal death ↑ CG night time 
wake after sleep onset & daytime 
total sleep time. Night time sleep 
percent ↓. Night time total sleep 
time did not change. Placement of 
spouse had no significant effect on 
CG sleep.  
Von 
Känel et 
al. (2012b) 
-CG: N = 119 
-Non-CG: N = 
58  
 
-CG: Mean age = 74.4, SD = 8.1 
F = 69.7%, M = 30.3% 
113 Caucasian 
-Non-CG: Mean age = 74.9, SD 
= 6.2  
F = 67.2%, M = 32.8% 
50 Caucasian, 5 African American, 
9 Other 
All spouses Mean duration = 
4.4 years, SD = 
3.4  
Glomerular 
filtration rate 
(GFR) 
CG: No difference in change in 
GFR at follow-up. GFR ↓ 
disproportionately 3 months after 
placement of spouse in nursing 
home. Effect stronger in CG with 
hypertension or ↑ DBP levels  
Zhang et 
al. (2001) 
-CG: N = 93 
-Non-CG = 91 
-CG: M = 69.9, SD = 7.4  
F = 66%, M = 34% 
-Non-CG: M = 69.1, SD = 5.4 
F = 71%, M = 29% 
All Caucasian 
All spouses Male CG: Mean 
duration = 45.5 
months, SD = 20.8 
Female CG: Mean 
duration = 52.7 
months, SD = 30.6 
Glucose 
 
Higher Sense of coherence = ↓  
glucose in males (both CG and 
non-CG)  
 
Table 7: Studies examining interventions to reduce impact of dementia caregiving on biomarkers of stress 
Article Intervention Sample size Participant age, 
gender & 
ethnicity 
Relation to care 
recipient 
Level of care 
provided 
Biomarkers 
examined 
Findings 
Aboulafia-
Brakha et al. 
(2014) 
Cognitive 
behavioural 
therapy (CBT) v 
Psycho-
education (PE) 
-CBT: N = 12 
-PE: N = 15  
 
-CBT: Mean age: 
59.42, SD = 6.67 
All female 
-  
-PE: Mean age = 
55.07, SD = 10.68 
 F = 10, M = 5  
- 
-CBT: 9 
spouses, 2 
children, 1 other 
-PE: 12 spouses, 
2 children, 1 other 
-CBT: Mean level 
= 6 hours/day, SD 
= 2.09 
PE: Mean level = 
5.40 hours per day, 
SD = 2.35 
Salivary cortisol CBT: ↓ salivary 
cortisol levels post-
intervention, not in PE 
 
Black et al., 
(2013) 
Kirtan Kriya 
Meditation 
(Med) v. 
-Med: N = 23 
-Music: N = 16   
-Med: Mean age = 
60.5 SD = 28.2  
F = 100%  
- 
 
 
- Med: Mean 
duration = 4.7 
years, SD = 2.4  
Genome-wide 
transcriptional 
analysis  
Med: ↓ expression of 
genes bearing NF-κB-
response elements, and ↑ 
relaxing music 
control (Music) 
 
- 
-Music: Mean age 
= 60.6, SD = 12.5 
 F = 88%, M = 12%  
- 
 
 
Mean level= 47.8 
hours/week, SD = 
35.8  
- Music: Mean 
duration = 4.2 
years, SD =2.9 
Mean level =  63.3 
hours/week, SD = 
36.2 
 
 expression of genes 
bearing Interferon 
Response Factor 1 
response elements 
Danuclav et 
al. (2013) 
Yoga & 
Compassion 
Meditation 
Program 
(YCMP). 
-YCMP: N = 
25 
-Control: N = 
21 
 
-YCMP: Mean age 
= 55.5, SD = 8.1  
 F = 22, M = 3.  
-  
-Control: Mean age 
= 53.4, SD = 8.2  
- -YCMP: Mean 
duration = 4.2 
years, SD = 3.3  
–Control: Mean 
duration = 5.7 
years, SD = 3.7 
Salivary cortisol 
(waking, 30 mins 
post-waking) 
 
YMCP: ↓ cortisol post-
intervention, not in 
control 
 
v. No treatment 
control (Control) 
F = 19, M = 2.  
-  
 
 
Garand et al. 
(2002) 
Progressively 
Lowered Stress 
Threshold 
(PLST) v. 
comparison 
intervention with 
information, 
psychological 
support, 
community 
services 
(comparison) 
-CG: N = 37 Mean age = 65.49, 
SD = 10.75  
F = 92%, M = 8% 
All Caucasian 
 
73% spouses 
 
Mean = 61.51 
months ago since 
diagnosis, SD = 
63.17  
Mean level: PLST: 
Mean = 161.57 
hours/week, SD = 
46.27 
Comparison: M = 
133.35 hours/ 
week, SD = 46.27  
NK cell 
cytotoxicity, T-
cell proliferation 
to PHA and 
concanavalin A 
 
PLST: ↑ T-cell 
proliferation to PHA and 
con, including at 6-
month follow-up 
 
Grant et al. 
(2003) 
Respite: 10 days 
of in-home help 
v. non-respite 
control 
-Vulnerable 
CG: N = 27 
-Non-
vulnerable CG: 
N = 28  
-Vulnerable CG: 
Mean age = 72.07, 
SD = 6.32  
F=55.6%, 
M=44.4%.  
89.3% White, 
10.7% non-White 
-Non-vulnerable 
CG: Mean age = 
74.54, SD = 4.05 
F = 67.9%, M = 
32.1%  
100% White 
All spouses At least 27 
providing more 
than 12 hours/day 
(vulnerable CG) 
BP 
HR 
EPI 
NE 
 
In vulnerable CG, at 1-
month follow-up, respite 
↓ plasma EPI, but 
waitlist ↑. No effect for 
NE, HR, BP 
Holland et al. 
(2011) 
Coping with 
Caregiving 
(CwC) v. 
-CwC: N = 90 
-TSC: N = 85 
Mean age = 58.21, 
SD = 13.76 
All female 
38.3% spouse Mean duration = 
4.24 years, SD = 
4.12 
Salivary cortisol 
(waking, 5pm, 
9pm) 
CG intensity (hours + 
cohabit): ↓ baseline cort- 
telephone 
support control 
(TSC) 
53.1 % Caucasian, 
46.9% Hispanic 
/Latino 
- 
Mean level = 10.18 
hours/day, SD = 
7.2   
 at waking and flatter 
across day  
CwC: no main effect on 
cort, but high intensity 
CG had dysregulation 
reversed by intervention 
Innes et al. 
(2012) 
Kirtan Kriya 
Meditation 
(Med) 
(No control 
condition) 
 
-CG: N = 5 
(with 5 care 
recipients) 
Mean age = 71.5, 
SEM = 5.25 (1 
person dropped 
out) 
F = 3, M = 3  
All non-Hispanic 
White 
 
5 spouses, 1 
daughter 
- BP, heart rate, 
cognitive status 
 
CG: ↑ retrospective 
memory and ↓ SBP. 
Trend for BDP 
Kim et al. 
(2011) 
Support program 
(SP), 8 weeks, 2-
-SP: N = 25 
-Control: N = 
19 
-SP: Age: N = 1: 
80+ years, N = 8: 
60-69, N = 10: 50-
-SP: 6 Daughters-
in-law, 1 son, 10 
-SP: Duration of 
care: 20 = 5 years 
EPI, NE 
 
-SP: No sig. change in 
NE, but was ↑ for 
control, no effect on EPI. 
3 hours per 
session 
v. no 
intervention 
(Control) 
59, N = 4: 40-49, N 
= 2: below 40  
F = 24, M = 1 
- 
-Control: Age: N = 
3: 80+, N = 1: 70-
79, N = 10: 60-69, 
N = 3: 50-59, N = 2: 
40-49  
F = 16, M = 3 
- 
daughters, 4 
spouses, 4 sisters  
-Control: 5 
daughter-in-laws, 
1 son, 3 
daughters, 9  
spouses, 1 sister 
 
or less, 4 = 6-15, 1 
= 16 or more  
-Control: Duration 
of care: 9 = 5 years 
or less, 6 = 6-15, 4 
= 16 or more 
 
No baseline difference in 
EPI/NE.  
 
King et al. 
(2002b) 
Home-based 
exercise v. 
nutrition 
education as 
attention control 
-Exercise: N = 
45 
-Control: N = 
40 
-Exercise: Mean 
age =  62.2, SD = 
9.3 
-Control: Mean age 
= 63.3, SD = 9 
-Exercise: 55.6% 
spouse 
-Control: 50% 
spouse  
 
Mean duration = 4 
years 
Mean level = 72 
hours/week 
HR, BP (in 
response to 
emotional 
challenge) 
 
Exercise: ↓ BP reactivity 
to emotional stressor   
All female 
86% White 
Lavretsky et 
al. (2013) 
Kirtan Kriya  
Meditation 
(Med) v Music 
control (Music) 
-CG: N = 39 
-Med: N = 23 
-Music: N = 16 
-Med: Mean age = 
60.5, SD = 28.2  
All female 
-Control: Mean age 
= 60.6, SD = 12.5 
F = 14, M = 2  
- 
13 spouses, 36 
children (at 
screening) 
-Med: Mean 
duration = 4.7 
years, SD = 2.4 
Mean level = 47.8 
hours/week, SD = 
35.8  
-Control: Mean 
duration = 4.2 
years, SD = 2.9 
Mean level = 63.3 
hours/week, SD = 
36.2 
Telomerase 
activity, verbal 
memory, attention 
and processing 
speed, executive 
function 
 
Med: ↑ MMSE and 
Trailmaking B 
(executive function).  
↑ telomerase activity 
 
 
Leach et al. 
(2015) 
Transcendental 
meditation (TM) 
course v. waitlist 
control (waitlist) 
-TM: N = 8 
-Waitlist: N = 9 
-TM: Mean age = 
69.4, SD = 7.3. 
F = 7, M = 1 
- 
-Waitlist: Mean age 
= 63.2, SD = 8.8 
F = 8, M = 1 
- 
-TM: 5 spouses, 3 
children  
-Waitlist: 6 
spouses, 3 
children 
 
-TM: Mean 
duration = 6.75 
years, SD = 3.57 
 Mean level = 
118.06 
hours/week, SD = 
68.9  
 -Waitlist: Mean 
duration = 4.21 
years, SD = 3.32  
Mean level = 
125.71 
hours/week, SD = 
72.27  
Cognitive 
performance 
(response speed, 
impulsivity, 
attention & 
concentration, 
information 
processing 
efficiency, 
memory, 
executive 
function, emotion 
identification, 
emotion bias) 
 
TM: ↑ response speed 
McKenzie et 
al. (2013) 
CBT   
(No control 
condition) 
-CG: N = 12 Mean age = 70.17, 
SD = 7.15 
F = 91.7% 
All White  
All spouses Mean level = 9.46 
hours/day, SD = 
9.42 
Cognition CBT: ↑ cognition total 
index; ↑ attention, 
immediate and delayed 
memory 
Moore et al. 
(2013) 
Pleasant events 
program (PEP) 
v. info support 
(IS) 
 
-PEP: N = 49 
-IS: N = 51 
-PEP: Mean age = 
70.86, SD = 7.57 
F = 81.6%, M = 
18.4%  
89.8% Caucasian 
-IS: Mean age = 
71.33, SD = 9.08 
F = 66.7% M = 
33.3% 
90.2% Caucasian 
Family members PEP: Mean 
duration = 5.42 
years, SD = 4.91  
Mean level  = 8.22 
hours/day, SD = 5 
IS: Mean duration 
= 3.95 years, SD = 
2.41 
Mean level = 8.02, 
SD = 5.38 
D-dimer, IL-6 
 
PEP: ↓ IL-6 more than 
IS, though not 
maintained at 1-year 
follow-up 
No sig difference 
between treatments for 
D-dimer. 
Oken et al. 
(2010) 
Mindfulness-
based cognitive 
therapy 
(MBCT), v. 
educational class 
adapted from 
Powerful Tools 
for 
Caregivers(PTC) 
v. respite-only 
interventions 
(Control) 
-CG: N = 31 -MBCT: Mean age 
= 62.5, SD = 11.6 
F = 8, M = 2 
8 White, 1 AA, 1 
Asian 
-PTC: Mean age = 
67.1, SD = 8.4 
F = 8, M = 3 
8 White, 1 Asian 
-Control: Mean age 
= 63.8, SD = 7.9 
F = 9, M = 1 
10 Caucasian 
 
-MBCT: 7 
spouses, 3 
children 
-PTC: 8  spouses, 
3 children 
-Control: 8 
spouses, 2 
children 
 
Level: At least 12 
hours/week 
Salivary cortisol, 
cognition (Stroop 
colour and word 
test, ANT) 
 
MBCT & PTC: ↑ ANT 
alerting score.  
PTC: ↑ Stroop 
performance 
No differences in 
cortisol 
 
Pomykala et 
al. (2012) 
Kundalini Yoga 
v. relaxation 
control (RC) 
 
-Yoga: N = 4 
-RC: N = 5 
-Yoga: Mean age = 
56, SD = 10.1. 
All female  
- 
RC: Mean age = 
49.8, SD = 3.9 
F = 4, M =1 
- 
- Yoga: Mean 
duration = 7.8 
years, SD = 2.9 
RC: Mean duration 
= 4.2 years, SD = 
3.6 
Level: At least 3 
days per week 
PET 
 
Yoga: ↓ metabolism 
over time in right 
inferior frontal cortex, 
right posterior cingulate 
cortex, left associative 
visual cortex. ↑ left 
superior frontal cortex, 
right lentiform nucleus, 
bilateral cerebellar 
metabolism. Yoga 
showed smaller ↑ right 
anterior hippocampus  
Vedhara et al. 
(2003) 
Cognitive-
behavioural SMI 
course 
-CG: N = 43 
-Non-CG: N = 
27 
-CG: Mean age = 
75 years, SD = 7 
F = 24, M = 19 
42 White/European  
All spouses Mean duration = 4 
years, SD = 2 since 
diagnosis 
Saliva cortisol, 
IgG response to 
vaccination 
 
CG: no difference on 
salivary cort. Cortisol 
highest mid-course. 
CBT: ↑ IgG response 
(No control 
condition) 
 
-Non-CG: Mean 
age = 71 years, SD 
= 4  
F = 14, M = 13 
26 White/European 
Mean level = 16 
hours/day, SD = 6 
and more likely to show 
clinically appropriate 
level of response to viral 
strain  
Wilkins et al. 
(1999) 
Psycho-
education (PE; 
coping skills + 
CBT)  
(No control 
condition) 
-CG: N = 11 Mean age = 70, SD 
= 5.7 
All female 
6 Caucasian, 4 AA, 
1 Hispanic 
All spouses - T cell proliferation 
capacity in 
response to 
phytohemaglutinin 
antigen (PHA) 
PE: ↓ immune function 
post-intervention, but 
trend for improvement at 
1 month follow-up  
Williams et 
al. (2010) 
Video-based 
coping skills 
(VSC) v. waitlist 
control (control) 
-VSC: N = 59 
-Control: N = 
57 
-VSC: Mean age = 
62.1, SD = 13.6 
 F = 44, M = 15 
37 Caucasian, 20 
AA, 1 other 
-VSC: 30 
spouses, 22 
children, 7 other 
-VCS: Mean = 42 
months since 
diagnosis, SD = 35  
-Waitlist: Mean = 
45, SD = 32 
BP, HR, salivary 
cortisol (in 
response to stress 
and at waking-i.e. 
VCS: ↓ DBP and SBP, 
no effect for BP/HR 
reactivity to stress. No 
effect on cortisol  
-Waitlist: Mean age 
= 59, SD = 12.8 
F = 46, M = 11 
36 Caucasian, 20 
AA 
-Control: 17 
spouses, 36 
children, 4 other 
 
 
 waking, wake +30 
mins, after 6pm) 
 
 
     
Table 8: Quality assessment of literature reviewed 
Study 
Selection 
bias 
Exposure 
bias 
Outcome 
bias 
 
Confounding 
bias 
 
Analytical 
bias 
Attrition 
bias 
Overall 
risk of 
bias 
Aboulafia-Brakha et al. (2014) Low High Minimal Low Low Low 
Low-
Moderate 
Adler et al. (2002) Moderate High Minimal High Low N/A 
Low-
Moderate 
Aschbacher et al. (2005) Low High Moderate Minimal Low N/A 
Low-
Moderate 
Aschbacher et al. (2006) Moderate Low Minimal Minimal Moderate 
Unclear 
(moderate) 
Low-
Moderate 
Aschbacher et al. (2008) Low Low Minimal Minimal Moderate N/A Low 
Aschbacher et al. (2009) Moderate High Minimal Minimal Moderate Moderate Moderate 
Aschbacher et al. (2013) Low Low Minimal Minimal Moderate N/A Low 
Atienza, et al. (2001) Minimal Minimal Minimal Minimal Low N/A Minimal 
Bauer, et al. (2000) Low Low Minimal Minimal Moderate N/A Low 
Black et al. (2013) Low Low Minimal Minimal Moderate Low Low 
Bristow, et al. (2008) Low High Minimal Minimal High N/A 
Low-
Moderate 
Brummet et al. (2005) Minimal Low Moderate Minimal Low N/A Low 
Brummet et al. (2007) Low High Minimal Minimal Moderate N/A 
Low-
Moderate 
Brummet et al. (2008) Low High Minimal Minimal Low N/A 
Low-
Moderate 
Brummet et al. (2013) Low High Moderate Minimal Low Moderate Moderate 
Burns et al. (2002) Minimal High Minimal Minimal Moderate N/A 
Low-
Moderate 
Cacioppo et al. (1998) Minimal Low Minimal Minimal Moderate N/A Low 
Cacioppo et al. (2000) Minimal Low Minimal Minimal Moderate N/A Low 
Castle et al. (1995) Moderate High Minimal High Moderate N/A Moderate 
Caswell et al. (2003) Minimal High Minimal Low Moderate N/A 
Low-
Moderate 
Chattillion et al. (2012) Low Low Minimal Minimal Moderate N/A Low 
Chattillion et al. (2013) Low Low Minimal Minimal Low N/A Low 
Clark et al. (2007) Moderate Low Moderate High Low Moderate Moderate 
Correa et al. (2015) Low Low Minimal Minimal Low N/A Low 
Da Roza Davis & Cowen (2001) Minimal High Minimal Low Moderate N/A 
Low-
Moderate 
Damjanovic et al. (2007) Moderate Low Minimal Low Moderate N/A 
Low-
Moderate 
Danucalov et al. (2013) Low Low Minimal Minimal Moderate Moderate 
Low-
Moderate 
Davis et al. (2004) Low Minimal Moderate Minimal Minimal Low Low 
de Vugt et al. (2005) Low Low Moderate Minimal Low N/A 
Low-
Moderate 
de Vugt et al. (2006) Moderate Low Minimal Minimal Low Moderate 
Low-
Moderate 
Epel et al. (2010) Low Low Minimal Minimal Moderate Minimal Low 
Esterling et al. (1994) Low Low Minimal Minimal Low N/A Low 
Esterling et al. (1996) Low Low Minimal Minimal Low N/A Low 
Fonareva et al. (2011) Low High Moderate Minimal Moderate N/A Moderate 
Gallagher-Thompson et al. (2006) Minimal Low Moderate Minimal Moderate N/A 
Low-
Moderate 
Garand et al. (2002) Low Low Minimal Minimal Moderate Low Low 
Glaser & Kiecolt (1997) Moderate Low Minimal Minimal Low N/A Low 
Glaser et al. (1998) Moderate Low High Minimal Moderate N/A Moderate 
Glaser et al. (2000) Low Low High Minimal Moderate N/A 
Low-
Moderate 
Glaser et al. (2001) Low Low Minimal Minimal Moderate N/A Low 
Gouin et al. (2012) Low Low Moderate Minimal Moderate N/A 
Low-
Moderate 
Graham et al. (2006) Low Low Moderate Minimal Low N/A 
Low-
Moderate 
Grant et al. (2003) Low Low Minimal Minimal Low Low Low 
Hadjiconstantinou et al. (2001) Low Low Moderate Minimal Low N/A 
Low-
Moderate 
Harmell et al. (2011) Low Low Minimal Minimal Low N/A Low 
Ho et al. (2014) Low Low Moderate Minimal Moderate N/A 
Low-
Moderate 
Holland et al. (2010) Minimal Low Minimal 
Unclear 
(Moderate) Low Low Low 
Holland et al. (2011) Low Low Minimal Minimal Moderate Moderate 
Low-
Moderate 
Innes et al. (2012) Moderate High Moderate High Moderate Low 
Moderate-
High 
Irwin et al. (1991) Low High Minimal Minimal Moderate N/A 
Low-
Moderate 
Irwin et al. (1997) Low Low Minimal Minimal Low N/A Low 
Irwin et al. (2013) Moderate High Minimal Minimal Moderate N/A 
Low-
Moderate 
Jeckel et al. (2010) Low Low Minimal Minimal Low N/A Low 
Kiecolt-Glaser et al. (1991) Moderate Low Minimal Minimal Low Moderate 
Low-
Moderate 
Kiecolt-Glaser et al. (1995) Low Low Minimal Minimal Low N/A Low 
Kiecolt-Glaser et al. (1996) Moderate Low Minimal Minimal Low Moderate 
Low-
Moderate 
Kiecolt-Glaser et al. (2003) Low Low Moderate Minimal Low 
Unclear 
(moderate) 
Low-
Moderate 
Kiecolt-Glaser et al. (2011) Minimal High Minimal Minimal Moderate N/A 
Low-
Moderate 
Kim et al. (2007) Moderate Minimal Minimal Minimal Low N/A Low 
Kim et al. (2011) High Low Moderate Low High N/A 
Moderate-
High 
King et al. (2002a) Low Low Minimal Minimal Low N/A Low 
King et al. (2002b) Low Low Moderate Minimal Low Low 
Low-
Moderate 
Klein et al. (2014) Minimal Low Minimal Minimal Low Minimal Minimal 
Knight & McCallum (1998) Low High Minimal Minimal Low N/A 
Low-
Moderate 
Knight et al. (2007) Minimal Low Minimal Minimal Moderate N/A Low 
Kring et al. (2010) Low High Moderate Minimal Low N/A 
Low-
Moderate 
Lavretsky et al. (2013) Low Low Moderate Minimal Low Moderate 
Low-
Moderate 
Leach et al. (2015) Low Low Moderate Minimal Moderate Minimal 
Low-
Moderate 
Leggett et al. (2014) Moderate Low High Minimal Moderate Minimal Moderate 
Li et al. (2007) Moderate High Minimal Minimal Low Moderate 
Low-
Moderate 
Lutgendorf et al. (1999) Low High Moderate Minimal Moderate N/A Moderate 
McCallum et al. (2006) Low Low Moderate Low Moderate N/A 
Low-
Moderate 
McKenzie et al. (2013) Moderate Low Moderate Low Moderate Moderate Moderate 
Malarkey et al. (1996) Moderate High Minimal Low Moderate N/A Moderate 
Mausbach et al. (2005) Moderate High Minimal Minimal Low N/A 
Low-
Moderate 
Mausbach et al. (2006) Moderate High Minimal Minimal Moderate N/A 
Low-
Moderate 
Mausbach et al. (2007a) Low High Moderate Low Moderate High Moderate 
Mausbach et al. (2007b) Moderate High Minimal Minimal Low N/A 
Low-
Moderate 
Mausbach et al. (2007c) Low Low Minimal Minimal Low Moderate Low 
Mausbach et al. (2008) Low Minimal Minimal Minimal Low High 
Low-
Moderate 
Mausbach et al. (2010) Moderate Low Minimal Minimal Low N/A Low 
Mausbach et al. (2012) Low Low Minimal Minimal Low High Low 
Merritt et al. (2011) Minimal Minimal Moderate Minimal Moderate N/A Low 
Merritt & McCallum (2013) Minimal Minimal Minimal Minimal Low N/A Minimal 
Mills et al. (1997) Low High Minimal Minimal Moderate N/A 
Low-
Moderate 
Mills et al. (2004) Low Low Minimal Moderate Moderate Moderate 
Low-
Moderate 
Mills et al. (2009) Low High Minimal Minimal Low N/A 
Low-
Moderate 
Mills & Yu (1999) Low Low Minimal Minimal Moderate N/A Low 
Moore et al. (2013) Low Minimal Minimal Minimal Low Moderate Low 
Neri et al. (2007) Moderate Low High High Low N/A 
Moderate-
High 
Oken et al. (2010) Moderate Low Minimal Moderate Moderate N/A 
Low-
Moderate 
Oken et al. (2011) Low Low Moderate Minimal Low N/A 
Low-
Moderate 
Palma et al. (2011) Low Low Minimal Low Moderate N/A 
Low-
Moderate 
Pomykala et al. (2012) Low Low Minimal Minimal Low Low Low 
Redwine et al. (2004) Moderate Low Minimal Minimal Moderate N/A 
Low-
Moderate 
Reese et al. (1994) Minimal Low Moderate Minimal Low N/A Low 
Roepke et al. (2008) Moderate Low Moderate Minimal Low N/A 
Low-
Moderate 
Roepke et al. (2011a) Low Low Minimal Minimal Low N/A Low 
Roepke et al. (2011b) Low Low Moderate Minimal Low N/A 
Low-
Moderate 
Roepke et al. (2012) Low Low Minimal Minimal Low N/A Low 
Sakurai et al. (2015) Low Low Moderate Minimal Moderate Minimal 
Low-
Moderate 
Sarabia-Cobo et al. (2015) Low Low Moderate High Minimal Minimal 
Low-
Moderate 
Scanlan et al. (1998) Low Low Minimal Minimal Moderate Moderate 
Low-
Moderate 
Scanlon et al. (2001) Low Low Minimal Minimal Moderate Low Low 
Schwartz et al. (2013) Moderate Low Moderate Minimal Moderate N/A 
Low-
Moderate 
Segerstorm et al. (2008) Low Low Moderate Low Moderate Moderate Moderate 
Shaw et al. (2003) Low Low Moderate Minimal Moderate Low 
Low-
Moderate 
Shaw et al. (1999) Low Minimal Moderate Minimal Moderate Low 
Low-
Moderate 
Stalder et al. (2014) Low Low Minimal Minimal Low N/A Low 
Tarrier et al. (2002) Moderate Minimal Minimal Low Low N/A Low 
Thompson et al. (2004) Moderate Low Minimal High Low N/A 
Low-
Moderate 
Tomiyama et al. (2012) Low High Minimal Minimal Moderate N/A 
Low-
Moderate 
Uchino et al. (1992) Low Low Minimal Minimal Moderate N/A Low 
Uchino et al. (1994) Low Low Moderate Minimal Moderate Moderate 
Low-
Moderate 
Vedhara et al. (1999) Low Low Minimal High Moderate 
Unclear 
(moderate) Moderate 
Vedhara et al. (2003) Low Low Minimal High Moderate Minimal 
Low-
Moderate 
Vitaliano et al. (1995) Low High Minimal Minimal Moderate N/A 
Low-
Moderate 
Vitaliano et al. (1996a) Minimal Low Moderate Minimal Low 
Unclear 
(moderate) 
Low-
Moderate 
Vitaliano et al. (1996b) Low Low Minimal Minimal Moderate N/A Low 
Vitaliano et al. (1996c) Low Low Minimal Minimal Moderate N/A Low 
Vitaliano et al. (1998a) Low Low Minimal Minimal Low Minimal Low 
Vitaliano et al. (1998b) Low Low Minimal Minimal Low Low Low 
Vitaliano et al. (2001) Low High Moderate Minimal Moderate Minimal 
Low-
Moderate 
Vitaliano et al. (2002) Low Minimal Moderate Minimal Moderate Low 
Low-
Moderate 
Vitaliano et al. (2005) Moderate High Minimal Minimal Moderate Low  
Vitaliano et al. (2007) Moderate Low Minimal Minimal Moderate Minimal  
Vitaliano et al. (2009) Low Low Minimal Minimal Low Minimal Low 
Von Känel, et al. (2001) Moderate High Minimal Minimal Moderate N/A 
Low-
Moderate 
Von Känel, et al. (2003) Moderate High Minimal Minimal Moderate N/A 
Low-
Moderate 
Von Känel, et al. (2005) Low High Minimal Minimal Moderate N/A 
Low-
Moderate 
Von Känel et al. (2006a) Low High Moderate Minimal Moderate N/A Moderate 
Von Känel et al. (2006b) Low High Minimal Minimal Moderate N/A 
Low-
Moderate 
Von Känel, et al. (2010a) Low High Minimal Minimal Moderate N/A 
Low-
Moderate 
Von Känel, et al. (2010b) Moderate Low Moderate Minimal Low Moderate 
Low-
Moderate 
Von Känel, et al. (2011a) Low Low Moderate Minimal Low N/A 
Low-
Moderate 
Von Känel, et al. (2011b) Low Low Moderate Minimal Low N/A 
Low-
Moderate 
Von Känel, et al. (2012a) Low Low Minimal Minimal Low N/A Low 
Von Känel, et al. (2012b) Low Low Moderate Minimal Low Low 
Low-
Moderate 
Von Känel, et al. (2012c) Low Low Moderate Minimal Low Minimal Low 
Von Känel, et al. (2014) Moderate Low Moderate Minimal Moderate 
Unclear 
(moderate) Moderate 
Wahbeh et al. (2008) Low High Moderate Minimal Moderate N/A Moderate 
Wilkins et al. (1999) High High High Minimal Moderate Moderate 
Moderate-
High 
Wilcox et al. (2005) Moderate Minimal Minimal Minimal Moderate N/A Low 
Williams et al. (2010) Moderate Low Moderate High Moderate Unclear 
Moderate-
High 
Wu et al. (1999) Moderate High Minimal Low Moderate Low Moderate 
Zarit et al. (2014) Minimal Low Minimal Low Low N/A Low 
Zhang et al. (2001) Low Low Minimal Low Moderate 
Unclear 
(moderate) 
Low-
Moderate 
Zhang et al. (2006) Low High Minimal Minimal Moderate 
Unclear 
(moderate) 
Low-
Moderate 
 
 
 
